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- ABSTRACT -
THE ARF-GEFS GEA1 AND GEA2 INTEGRATE SIGNALS 
TO COORDINATE VESICLE TRAFFICKING AT THE GOLGI COMPLEX 
Margaret Ann Gustafson, Ph.D. 
Cornell University 2017 
At the Golgi complex, the biosynthetic sorting center of the cell, the Arf GTPases are responsible 
for coordinating vesicle formation. The Arf-GEFs activate Arf GTPases and are therefore the key 
molecular decision-makers for both anterograde and retrograde trafficking out of the 
Golgi.  In Saccharomyces cerevisiae, three conserved Arf-GEFs function at the Golgi: Sec7, Gea1, 
and Gea2.  Our group has described the regulation of Sec7, the trans-Golgi Arf-GEF, through 
autoinhibition, positive feedback, dimerization, and interactions with a suite of small 
GTPases.  However, we lack a clear understanding of the regulation of the early Golgi Arf-GEFs 
Gea1 and Gea2.  Here, I present insights into this regulation. 
I demonstrate that Gea1 and Gea2 prefer neutral over anionic membrane surfaces in vitro, 
consistent with their localization to the early Golgi, and that Gea1, Gea2, and Sec7 each localize 
to different Golgi compartments.  I also show that a critical mass of either Gea1 or Gea2 is 
required for the essential role which Gea plays in vivo. 
Using in vitro membrane binding and catalytic activity assays, I show that the C-terminal 
domains of Gea1 and Gea2 toggle roles in the cytosol and at the membrane surface, preventing 
membrane binding by Gea in the absence of a recruiting interaction but promoting maximum 
catalytic activity once recruited.  In vivo assays highlight the importance of these domains in 
recruitment of Gea to Golgi compartments and cell viability. 
 
I have identified the small GTPase Ypt1 as a recruiter for Gea1 and Gea2 in vitro, and I 
demonstrate that this interaction is dependent upon the C-terminus of Gea.  I have also 
uncovered an additional interaction between Gea2 and the Golgi SNARE Gos1 which may 
provide the specific interaction required to target Gea1 and Gea2 to different compartments.  I 
describe additional preliminary results and propose future experiments that will advance this 
line of research. 
 
This evidence evokes a model for intricate regulation of function and localization for Gea1 and 
Gea2 and raises interesting questions about the roles Gea1 and Gea2 play in Golgi trafficking.  
My findings not only illuminate core regulatory mechanisms unique to the early Golgi Arf-
GEFs, but also pave the way for a clearer understanding of the coordination of Golgi membrane 
trafficking across transport events controlled by small GTPases, their regulators, and their 
effectors working in concert. 
 
 
 
 
  
- BIOGRAPHICAL SKETCH -
Maggie Gustafson was born and raised in Vienna, Virginia, before moving to Pennington, NJ, 
when she was twelve.  She graduated from Hopewell Valley Central High School in 2005. 
Maggie graduated with honors from the University of Richmond in 2009, earning a B.S. in 
Biochemistry and Molecular Biology and B.A in Latin American and Iberian Studies.  Her 
research with Dr. Michelle Hamm focused on the molecular mechanism of mutagenesis during 
DNA synthesis after oxidative DNA damage.  This work was published in 2011. 
In 2009, Maggie joined the lab of Dr. Joel Meyer in the Nicholas School of the Environment at 
Duke University, where she worked as a lab manager and research technician.  While there, she 
studied the effects of mitochondrial DNA damage at the molecular, cellular, and whole animal 
level in C. elegans.  This work culminated in two publications in 2012. 
Maggie enrolled in the graduate field of Biochemistry, Molecular and Cell Biology at Cornell 
University in 2011.  She joined Dr. Chris Fromme’s lab in May 2012, where she studied the 
mechanisms of regulation of Golgi membrane trafficking using protein biochemistry, yeast cell 
biology and microscopy, and x-ray crystallography.  This work culminated in two publications, 
one in 2016 and one in 2017 (in review). 
iii
DEDICATION 
 
              
 
 
 
 
 
 
 
To my mother and father, 
Lynn and Peter, 
who fostered in me the inquisitiveness, creativity, and passion that make me who I am. 
 
 
 
 
 
 
 
  
iv
ACKNOWLEDGMENTS 
I am grateful to my advisor, Chris Fromme, for his stalwart support, brilliant guidance, and infinite 
patience. 
I would like to thank my committee members, Eric Alani and Bill Brown, for their helpful feedback 
on my work, thoughtful mentorship, and training in and out of the classroom. 
I am so fortunate to have had wonderful mentors at every stage of my education: Karen Lucci at 
HVCHS, Michelle Hamm and Rob Miller at the University of Richmond, and Joel Meyer at Duke 
University. 
Thanks are due to Caitlin McDonold and Brian Richardson for laying the groundwork for my 
project and providing training and helpful discussions, and especially to my baymate Brian for 
moral support during difficult experiments. 
I am thankful for the opportunity to mentor two undergraduate researchers, Joe Manzi and Yi Fan 
Chen, who have worked diligently on Gea projects, as well as two rotation students, Jon Wasilko 
and Abigail Miller, who contributed experiments to this study. 
I appreciate the help and useful discussions provided by other members of the Fromme lab: Laura 
Thomas, Carolyn Diefenderfer, Steve Halaby, Aaron Joiner, Jon Paczkowski, and Amanda Weiskoff.  
It’s been wonderful working with such bright, interesting, and fun labmates. 
v
I have benefited a great deal from the collaborative nature of Cornell, the Weill Institute, and the 
department of Molecular Biology and Genetics, in particular from reagents, equipment, and advice 
provided by the following groups: S. Emr lab, T. Bretscher lab, H. Sondermann lab, M. Smolka lab, 
F. Hu lab, Y. Mao lab, the Macromolecular Diffraction Facility at the Cornell High Energy
Synchrotron source (MacCHESS), and the Cornell Institute of Biotechnology. 
I am thankful for Mary Godec, Sarah Griffin, and Nadia Nikulin, who have kept the Institute 
running and made my research indescribably easier over the years, and for the WICMB 
administrative staff and BMCB GFAs. 
This work was funded by NIH grant R01GM098621, NIH training grant T32GM007273, and the 
Harry and Samuel Mann Outstanding Graduate Student Award. 
I am so grateful for the wonderful friends I have made during my time in Ithaca – I couldn’t have 
done this without them. 
Thanks to my sister, Sarah, for always having my back. 
The encouragement and support of my parents, Lynn and Peter, made all of this possible. 
And thanks to Ian Hensley, for his love and support in everything that I do. 
vi
Biographical Sketch iii
Dedication iv
Acknowledgments v
Table of Contents vii
Chapter 1. Introduction 1
Figure 1.1. The endomembrane system and vesicle coat complexes. 3
Figure 1.2. The life cycle of a coated vesicle. 7
Figure 1.3. Arf1 GTPase cycle. 14
Figure 1.4. Rab and Arf GTPases in Golgi membrane trafficking. 17
Figure 1.5. Comparison of the domains of Sec7 family Arf-GEFs. 21
Chapter 2. Regulation of Arf activation occurs via distinct mechanisms at 27
early and late Golgi compartments
Introduction 27
Results 29
Figure 2.1. Gea1 and Gea2 localize differently relative to early and late Golgi markers. 30
Figure 2.2. The in vitro  membrane preferences of Gea1, Gea2, and Sec7 correspond to 32
their sub-Golgi localization in vivo.
Figure 2.3. GEF constructs used for biochemistry are pure and His6 tags were 34
successfully cleaved.
Figure 2.4. EDTA-induced Arf1 nucleotide exchange favors TGN over PC liposomes 35
in vitro.
Figure 2.5. Cells require a critical mass of either Gea1 or Gea2 for growth.  37
Figure 2.6. The HDS1 and HDS2 domains of Gea1 and Gea2 are required for 40
Figure 2.7. The C-terminus of Gea2 both inhibits membrane binding and contributes 43
to Arf1 nucleotide exchange.
Figure 2.8. Gea1 and Gea2 are recruited to membranes by the small GTPase Ypt1. 47
Figure 2.9. Neither Arl1 nor Ypt6 recruits Gea1 or Gea2 to membranes. 48
Figure 2.10. The C-terminus of Gea2 is required for recruitment by Ypt1. 50
 - TABLE OF CONTENTS - 
localization and essential in vivo,  while the HDS3 domain is dispensable.  
vii
Discussion 51
Figure 2.11. Model of Gea regulation. 53
Chapter 3. In pursuit of a crystal structure of Gea 58
Introduction 58
Results 58
Table 3.1. Constructs cloned and purified for crystallography. 60
Table 3.2. Crystallization screens and optimization conditions. 61
Table 3.3. Cryoprotectant strategies and crystals looped and shot. 66
Discussion 74
Figure 3.1. Gea1 rhomboid prism crystals produce diffraction at 10 Å resolution.  75
Chapter 4. The domains of Gea1 and Gea2 regulate localization and function 77
Introduction 77
Results 78
Figure 4.1. The HDS3 domain opposes membrane binding but is required for full 79
catalytic activity of Gea2 in vitro.
Figure 4.2. Secondary structure predictions identify a previously undocumented 81
α-helix C-terminal to the GEF domain of Gea1 and Gea2.
Table 4.1. Tests of reported point mutants. 83
Figure 4.3. Gea1 and Gea2 display different colocalization patterns.  86
Figure 4.4. Differential localization of Gea1 and Gea2 is determined by their 87
N-terminal domains. 
Table 4.2. N-terminal reciprocal point chimeras in Gea1 and Gea2. 90
Discussion 91
Chapter 5. Interacting partners of Gea1 and Gea2 direct localization 93
Introduction 93
Results 94
Table 5.1. Gea localization in single deletion strains. 95
Figure 5.1. Of the Golgi GTPases, only Ypt1 improves Arf1 activation by Gea. 97
Figure 5.2. Sequence conservation and molecular replacement were used to predict 99
possible Ypt1-binding residues in Gea2. 
Table 5.2. Potential Ypt1 binding mutants. 100
viii
Figure 5.3. The cytosolic tails of documented Gea2 interactors Gmh1 and Sft2 fail 103
to recruit Gea2 to membranes in vitro.
Figure 5.4. Gea2 interacts directly with the Golgi SNARE Gos1 in vivo.  105
Figure 5.5. Colocalization patterns show that Gea2, but not Gea1, 107
colocalizes with Gos1.  
Figure 5.6. The purified cytoplasmic domain of Gos1 recruits Gea2 109
to membranes in vitro.  
Discussion 111
Chapter 6. Future Directions 114
Appendices 119
Appendix I. Materials and Methods 119
Appendix II. Composition of liposomes used in this study 126
Appendix III. Yeast expression plasmids used in this study and developed 127
for future use
Appendix IV. Bacterial expression plasmids used in this study and developed 128
for future use
Appendix V. Yeast strains used in this study 130
References 131
ix
- CHAPTER 1 - 
INTRODUCTION 
 
Organization of eukaryotic cells          
Both eukaryotic and prokaryotic cells are complex and intricately organized.  Across the 
spectrum of cells, we find single-celled organisms as small as 1 µm in diameter, specialized 
mammalian cells as large as 100 µm in diameter, and even unusually large cells with diameters 
measured in millimeters and lengths in feet.  Yet all of these cells face similar challenges.  
Within these varying confines and with varying degrees of complexity, the same fundamental 
functions which permit cell survival and growth must be carried out: maintenance, replication, 
and transcription of DNA, translation, editing, and transport of RNA, modification, transport, 
and regulation of proteins, biogenesis and transport of sugars, lipids, and the building blocks of 
macromolecules, production of ATP which drives essential, energetically unfavorable reactions 
throughout the cell.  All of this must occur while maintaining the integrity of the cell in its 
environment and yet also allowing for exchange with the outside of the cell: sensing 
environmental changes, cell-cell communication, and uptake of extracellular molecules.  The 
plasma membrane and its supporting structures therefore represent critical and necessarily 
dynamic structures for all cells. 
 
In eukaryotic cells, the separation of functions is largely achieved through elaborate 
intracellular compartmentalization: eukaryotic cells contain numerous distinct organelles in 
which specific cellular functions are carried out.  And while each of these organelles must 
maintain its own identity, defined by its characteristic complement of macromolecules, there is 
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a great deal of communication and exchange among organelles.  For example, functions 
achieved in the nucleus are intrinsically linked to and regulated by events and molecules in the 
cytosol.  Many transcription factors remain in a cytosolic pool until signals for gene regulation 
send them into the nucleus through nuclear pores, where RNA is transcribed and must leave 
the nucleus through these same pores for editing and translation in the cytosol and at the 
endoplasmic reticulum (ER) (Whiteside and Goodbourn 1993; Köhler and Hurt 2007; Nyathi, 
Wilkinson, and Pool 2013). 
Most exchange between organelles, however, occurs through regulated fission and fusion of 
membranes (Figure 1.1 A).  The mitochondrial morphology is closely tied to, among other 
factors, the cell’s metabolic state, and mitochondria divide and fuse to maintain energetic 
homeostasis, protect themselves from autophagy, and preserve mitochondrial DNA integrity 
(Wai and Langer 2016).  Many other organelles in the cell participate in a complex membrane 
trafficking network, through which membrane-bound packets, called vesicles, bud from donor 
compartments and fuse with target compartments to deliver proteins and lipids.  In particular, 
newly synthesized transmembrane proteins and proteins destined for secretion rely on this 
membrane trafficking system for delivery to the plasma membrane (Palade 1975).  Along the 
way, each cargo protein must be modified and appropriately sorted multiple times, and specific 
and highly orchestrated sets of machinery have evolved to ensure that each delivery and receipt 
of cargo occurs at the correct time and place within the cell. 
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Figure 1.1.  The endomembrane system and vesicle coat complexes.  (A) Cartoon of the 
endomembrane system showing membrane trafficking pathways.  Lysosome, human; vacuole, 
yeast.  (B) Cartoon of the coat protein complexes which facilitate vesicle transport in various 
trafficking pathways.  Note that mammals do not have an exomer homolog.  AP-4 and AP-5 
adaptor complexes not shown. 
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Perturbations in these pathways result in a broad array of human diseases (Howell et al. 2006).  
Mutations which disrupt ER exit are implicated in cancer and liver, kidney, cardiac, and 
vascular disease, among others.  Those which compromise the formation of clathrin-coated 
vesicles are associated with leukemia and autoimmune diseases.  Many others are associated 
with neurodevelopmental or neurodegenerative diseases, such as Alzheimer’s and Parkinson’s 
diseases, which highlights the particular demands on membrane trafficking in human neurons.  
Accurate and timely trafficking between intracellular compartments and the plasma membrane 
is essential for eukaryotic cells from yeast through humans, and as our fundamental 
understanding of these processes grows more complete, so will our understanding of the 
human diseases caused by mutations which disrupt these processes. 
 
 
Trafficking within the endomembrane system       
The proteins and mechanisms which regulate membrane trafficking in eukaryotes are highly 
conserved (Schlacht et al. 2014).  Cells move newly synthesized proteins from the ER to the 
plasma membrane through a system called the secretory pathway.  This pathway, first 
described through electron microscopy of mammalian cells, was meticulously dissected in the 
relatively simple model organism Saccharomyces cerevisiae using temperature sensitive mutants 
to disrupt different trafficking steps and also characterized using isolated Golgi cisternae from 
mammalian cells (Palade 1975; P. J. Novick and Schekman 1979; P. Novick, Field, and Schekman 
1980; P. Novick, Ferro, and Schekman 1981; Balch, Glick, and Rothman 1984; Balch et al. 1984).  
Proteins are shuttled in vesicles or membrane-bound tubules from ER exit sites through the ER-
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Golgi intermediate compartment (ERGIC) to the cis-Golgi.  They then move through the Golgi, 
where some are modified by Golgi-resident enzymes, before repackaging into vesicles at the 
trans-Golgi network (TGN) and shipment to endosomes, the lysosome (vacuole in yeast) and 
the plasma membrane. 
 
This flow of anterograde traffic, carrying cargos destined for secretion or incorporation into the 
plasma membrane, is complemented by a retrograde trafficking pathways.  Endocytosis 
recycles plasma membrane proteins through endosomes back into the secretory pathway or to 
the lysosome (vacuole in yeast) for degradation.  Retrograde traffic from the Golgi to the ER 
facilitates the retrieval of ER resident proteins, vesicle fusion machinery, and misfolded 
secretory proteins to the ER. 
 
Retrograde traffic is also required among Golgi cisternae.  While the Golgi forms distinct 
perinuclear stacks in mammalian cells, yeast Golgi are spread through the cell as individual 
cisternae (Franzusoff et al. 1991; Preuss et al. 1992; Wooding and Pelham 1998).  This feature 
allowed the visualization and validation of a model of Golgi transport in which cisternae 
mature individually and retain their cargo, rather than remaining constant while secretory 
cargo are transferred forward between cisternae in vesicles (Losev et al. 2006; Matsuura-Tokita 
et al. 2006).  As each cisternae matures, resident Golgi proteins, such as glycosylation enzymes, 
must be recycled to new early compartments through vesicle transport.  It should be noted that 
there are arguments for a hybrid system, in which cisternal maturation is complemented by 
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anterograde vesicle and tubule trafficking of cargo within the Golgi (Martínez-Menárguez 2013; 
Morriswood and Warren 2013). 
 
Membrane tubules have also be shown to play a role in many of the trafficking events in the 
endomembrane system (Bonifacino and Lippincott-Schwartz 2003; De Matteis and Luini 2008; 
Bard and Malhotra 2006; Tomás et al. 2010; Heffernan and Simpson 2014; de Figueiredo et al. 
1998).  It has been proposed that these tubules are used for specific cargos or when trafficking 
demand is high, but a full picture of how vesicles and tubules cooperate to accomplish 
membrane trafficking is still emerging. 
 
 
Regulation and specificity in vesicle trafficking       
The general life cycle of a transport vesicle is common across trafficking events in the 
endomembrane system (Figure 1.2) (Bonifacino 2014).  An activated small guanosine 
triphosphatase (GTPase) binds to the donor membrane, where it recruits coat proteins.  The coat 
proteins interact with cargos and cargo adapters before the membrane deforms and eventually 
buds off.  As the vesicle travels to the target membrane – either by diffusion or through 
interactions with motor proteins which traverse the cytoskeletal network – it also loses its 
protein coat (Santiago-Tirado and Bretscher 2011; Kyoung and Sheets 2008; Trahey and Hay 
2010; Cai, Reinisch, and Ferro-Novick 2007).  At the target membrane, the vesicle is tethered, 
and then SNAP (soluble NSF attachment protein) receptor (SNARE) complex formation drives 
6
 
 
Figure 1.2.  The life cycle of a coated vesicle.  (A) Recruitment of GEF to membrane surface.  
(B) Nucleotide exchange and membrane insertion of Arf GTPase.  (C) Recruitment of coat 
proteins, cargos, and v-SNARE.  (D) Membrane deformation.  (E) Budding.  (F) GTP hydrolysis 
by Arf catalyzed by GAP drives vesicle uncoating.  (G) Transport to target membrane, either by 
diffusion or along cytoskeleton filaments.  (H) Vesicle tethering facilitated by Rab GTPase.  (I) 
Docking and fusion coupled to SNARE complex assembly.  (J) Release of soluble cargo and 
diffusion of transmembrane cargo and SNARE complexes.  (K) SNARE complex disassembly 
and SNARE recycling.  Note that not all coated vesicle trafficking involves Arf and Rab 
GTPases.  SNARE disassembly is an active process carried out by SNARE regulator proteins.   
 
Used as references: (Alberts et al. 2007; Bonifacino 2014)  
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membrane fusion (Rothman 1994; Mcnew et al. 2000; Pelham 2001; Malsam and Söllner 2011; 
Whyte and Munro 2002; Yu and Hughson 2010). 
 
Vesicle trafficking is tightly controlled so that cargos are appropriately packaged and delivered 
from one specific membrane to another.  The specificity of these events is determined by the 
machinery – GTPases, protein coats and adaptors, tethers, SNAREs – employed at each 
compartment and the interactions between each set of machinery and the cargos it is designated 
to transport. 
 
Vesicle coat complexes           
Most trafficking events involve specific vesicle coats: protein complex oligomers which form a 
cage around each vesicle and aide in cargo recruitment, membrane deformation, and fission 
(Figure 1.2 C) (Kirchhausen 2000; Paczkowski, Richardson, and Fromme 2015; Cai, Reinisch, 
and Ferro-Novick 2007; Bonifacino and Lippincott-Schwartz 2003).  Different coats are 
employed in different trafficking steps (Figure 1.1 B).  The first coat discovered, clathrin, is 
found on vesicles trafficked from the TGN and the plasma membrane, with specific adaptor 
proteins working at different donor membranes and for different cargos and destinations 
(Kirchhausen 2000; De Matteis and Luini 2008).  The adaptor protein 1 (AP-1) and Golgi-
localized, gamma-ear containing, ARF-binding (GGA) complexes function with clathrin in 
vesicle trafficking between the TGN and endosomes (De Matteis and Luini 2008).  AP-3 
functions in TGN-to-lysosome/vacuole transport, but interaction with clathrin is not essential 
for its function (Peden et al. 2002).  Two other adapter protein complexes, AP-4 and AP-5, have 
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more recently been described (Hirst, Irving, and Borner 2013).  AP-4 is believed to be required 
only for specific cargos trafficked from the TGN and functions independently from clathrin, 
while AP-5, despite clues that it functions as an adapter complex, remains largely 
uncharacterized (Hirst, Irving, and Borner 2013). 
 
AP-2 interacts with clathrin at the plasma membrane to coat endocytic vesicles for retrograde 
traffic from the plasma membrane (Kirchhausen 2000).  Retrograde traffic from endosomes to 
the TGN, an important pathway for recycling transmembrane protein receptors, utilizes the 
highly divergent retromer complex (Seaman 2005; Hierro et al. 2007). 
 
Anterograde traffic from the ER to the Golgi is largely mediated by coatomer protein complex II 
(COPII) coated vesicles (Barlowe and Schekman 1993).  COPII, while functionally similar to 
other protein coats, is structurally unrelated to clathrin and its adaptors  (Bonifacino and 
Lippincott-Schwartz 2003).  Retrograde vesicle traffic within Golgi compartments and from the 
Golgi to the ER relies on coatomer protein complex I (COPI), the membrane-proximal subunits 
of which share structural similarity with clathrin adaptor proteins (Waters, Serafini, and 
Rothman 1991; Bonifacino and Lippincott-Schwartz 2003). 
 
Some steps of trafficking remain unresolved.  A small percent of direct traffic between the TGN 
and the plasma membrane is mediated by the exomer complex in yeast, but no homologous 
complex has been identified for polarized transport in mammalian cells (Mellman and Nelson 
2008; Payne and Schekman 1985; Folsch 2008).  Exomer, a cargo adapter, also fails to interact 
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with any of the canonical protein coats, leaving open the question of how exomer-sorted 
vesicles undergo fission (Barfield, Fromme, and Schekman 2009; Wang et al. 2006). 
 
The recruitment of the correct vesicle coat to collect specific cargo is inextricable from the 
appropriate transport and targeting of vesicles to the correct acceptor compartments, not least 
because the coats ensure packaging of the appropriate SNAREs into vesicles.  To achieve this 
specificity, coat proteins rely on the coincidence of multiple interactions. 
 
Sorting signals in vesicle trafficking          
Sorting signals on the cytoplasmic domains of cargo proteins present one source of these 
specific interactions.  Clathrin and its AP-1, AP-2, AP-3, and AP-4 adaptors recognize YXXØ 
motifs in cargo proteins (where Ø may be leucine, isoleucine, phenylalanine, methionine or 
valine and X represents any amino acid) (Bonifacino and Lippincott-Schwartz 2003; Cocucci et 
al. 2012).  The GGA clathrin adaptor recognizes cargos with acidic dileucine (DXXLL) sorting 
signals as well as ubiquitinated cargos at the TGN (Takatsu et al. 2001; Puertollano et al. 2003; 
Bonifacino 2004).  The interaction between clathrin, its adaptors, and its cargo is intrinsic to its 
role in vesicle formation: upon recruitment to membranes displaying clathrin cargo, clathrin 
changes conformation, and the oligomerization of the clathrin cage drives membrane 
deformation and vesicle budding (B. T. Kelly et al. 2014). 
 
COPI binds canonical dilysine motifs, as well as arginine- and tryptophan-based signals, to 
recycle cargos within the Golgi and from the Golgi to the ER (Gomez-Navarro and Miller 2016; 
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L. P. Jackson et al. 2012).  The COPII subunit Sec24 serves as a binding scaffold for a variety of 
cargo sorting motifs – diacidic, dihydrophobic, and tyrosine-containing motifs, as well as 
sequences specific to SNAREs – permitting efficient sorting of diverse cargos for ER export (Sato 
and Nakano 2007).  Neither COPI nor COPII display the direct link between oligomerization 
and membrane deformation observed with clathrin, leading to the hypothesis that additional 
proteins recruited to the nascent vesicle contribute to vesicle budding (Gomez-Navarro and 
Miller 2016). 
 
Vesicle targeting and fusion           
After vesicles bud, they shed their coats, a process dependent either on GTP hydrolysis by the 
GTPases associated with COPI, COPII, and some clathrin vesicles or on hydrolysis of the 
phosphoinositide PI(4,5)P2 in the case of endocytic clathrin vesicles (Figure 1.2 F) (Trahey and 
Hay 2010; Cai, Reinisch, and Ferro-Novick 2007; Cremona et al. 1999).  The remaining proteins 
on each vesicle coordinate transport to, recognition of, and fusion with specific target 
membranes.  At the receiving end of vesicle transport, vesicle proteins interact with target-
specific tethers, which lends specificity to vesicle targeting (Figure 1.2 H) (Whyte and Munro 
2002; K.-Y. Chen et al. 2010).  Vesicle tethering facilitates vesicle docking, in which vesicle-borne 
v-SNAREs form a complex with target membrane t-SNAREs (Rothman 1994).  The zippering of 
the SNARE domains of each set of four SNARE proteins is very energetically favorable, and 
therefore the formation of SNARE complexes between the vesicle and target membranes is the 
driving force behind vesicle fusion (Figure 1.2 1-J) (Y. A. Chen and Scheller 2001).  Different sets 
of SNAREs are specific to each trafficking pathway, imparting further specificity to vesicle 
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targeting (Mcnew et al. 2000; Pelham 2001; Malsam and Söllner 2011).  The SNAREs, most of 
which are tethered by transmembrane proteins, must be unzipped by the action of NSF/α-
SNAP and recycled between compartments for reincorporation into new vesicles, and therefore 
also serve as cargos in retrograde trafficking steps (Figure 1.2 K) (Baker and Hughson 2016). 
 
Vesicle formation at donor membranes and fusion at target membranes relies on coincidence 
detection of multiple signals at the same place and time to ensure accuracy in membrane 
trafficking.  In addition to the specificity of membrane coats, sorting signals, tethering proteins, 
and SNARE complexes, the localization and timing of vesicle trafficking is tightly regulated 
through binary molecular switches: the small GTPases of the Arf and Rab families. 
 
 
The Ras superfamily of small GTPases         
The Arf and Rab families of GTPases belong to the Ras superfamily.  This superfamily is 
generally divided into five subfamilies based on similarities in sequence and function (Rojas et 
al. 2012).  The founding Ras sarcoma (Ras) and Ras homologous (Rho) families act in pathways 
which respond to extracellular stimuli, including regulation of the cytoskeleton, cell cycle 
progression, and control of gene expression (Wennerberg, Rossman, and Der 2005).  The Ras-
like nuclear (Ran) family is largely involved in the transport of RNA and proteins between the 
nucleus and cytoplasm, while the Ras-like proteins in brain (Rab) and ADP ribosylation factor 
(Arf) families feature widely in the organization of endomembrane trafficking (Wennerberg, 
Rossman, and Der 2005). 
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 Despite the breadth of cellular roles filled by its members, the superfamily is unified by several 
key features.  All members of the Ras superfamily, and some GTPases beyond it, share a highly 
conserved GDP/GTP binding motif called a G-domain (Wennerberg, Rossman, and Der 2005; 
Rojas et al. 2012).  Ras superfamily GTPases have high affinity for both GDP and GTP and low 
intrinsic rates of exchange for GTP and hydrolysis of GTP to GDP, so activation and inactivation 
of these GTPases present excellent opportunities for regulation (Luo et al. 2007; Mizuno-
Yamasaki, Rivera-Molina, and Novick 2012).  GTP exchange is facilitated by guanine nucleotide 
exchange factors (GEFs), while GTP hydrolysis is stimulated by GTPase-activating proteins 
(GAPs) (Figure 1.3) (Cherfils and Zeghouf 2011; Gillingham and Munro 2007b). Members of the 
superfamily undergo conserved, nucleotide-dependent conformational changes: two switch 
regions, Switch 1 and Switch 2, rearrange upon GTP binding (Cherfils and Zeghouf 2011).  
These conformational changes facilitate binding to effectors of the activated GTPases. 
 
Many Ras subfamilies, including the Arf and Rab families, rely on lipid modifications for 
membrane targeting (Wennerberg, Rossman, and Der 2005).  Arf family GTPases employ a 
myristoylated amphipathic helix which inserts into the membrane upon GTP binding (B 
Antonny et al. 1997).  The hydrophobic residues of this amphipathic helix are buried in the core 
of the protein when GDP-bound.  Members of the Rab family, on the other hand, sport a longer 
tail capped with two prenylated cysteines; these prenyl groups insert into the target membrane 
(E. E. Kelly et al. 2012).  Rab GTPases cannot pack away their lipid modifications, but rather rely 
on partners to remain soluble when inactive.  After translation, Rabs are bound by a Rab escort 
13
 
Figure 1.3. Arf1 GTPase cycle.  A GEF catalyzes the exchange of GDP for GTP on Arf1, 
inducing conformational changes in the Switch 1 and 2 regions and exposing the N-terminal 
amphipathic helix, which will insert into the membrane.  In this GTP-bound conformation, Arf1 
is active and can interact with effectors.  A GAP stimulates GTP hydrolysis by Arf1, releasing 
inorganic phosphate and returning Arf1 to its cytosolic, inactive state. 
 
Adapted from: (Gillingham and Munro 2007) 
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protein (REP) which allows lipid modification of the tail by a geranylgeranyl transferase 
(GGTase) (Alexandrov et al. 1994).  The REP facilitates the first membrane insertion of the Rab 
upon GTP exchange by its GEF.  When the Rab is inactivated by GTP hydrolysis, paired with its 
GAP, the Rab is bound by a GDP dissociation inhibitor (GDI), which shields the prenyl groups 
while the Rab remains in the cytosol (E. E. Kelly et al. 2012; Cherfils and Zeghouf 2013). 
 
Arf and Rab GTPases are involved in all stages of membrane trafficking.  Arf GTPases recruit 
protein coats to the site of vesicle formation and interact with cargos.  Arfs also count various 
lipid-metabolizing enzymes among their effectors, such as phospholipase D and PI kinases, 
coupling vesicle formation to changes in the donor membrane composition (Brown et al. 1993; 
De Matteis and Godi 2004).  Both Arfs and Rabs function in membrane deformation, fission, and 
uncoating of vesicles, while vesicle transport, target membrane recognition, and fusion are 
largely the domain of Rabs (E. E. Kelly et al. 2012; Goud and Gleeson 2010; Barr 2009). 
 
There is considerable overlap and cooperation between Arf and Rab GTPases in the secretory 
pathway.  Rab GTPases are well-documented to hand off cargos to one another in Rab cascades, 
where the GEF of the next Rab in line is an effector for the previous Rab and/or the GAP of the 
previous Rab is recruited by the next (Pfeffer 2012; Suda et al. 2013; P. Novick 2016).  Several 
Arf GTPases have shown to be regulated by positive feedback loops and interactions with other 
Arfs (Richardson, McDonold, and Fromme 2012; Stalder and Antonny 2013; McDonold and 
Fromme 2014).  There is also a great deal of cross talk between Arfs and Rabs, leading to 
recruitment of Arf-GEFs by Rabs and of Rab-GEFs by Arfs (Mizuno-Yamasaki, Rivera-Molina, 
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and Novick 2012; Cherfils and Zeghouf 2013; Stalder and Antonny 2013; Thomas and Fromme 
2016; McDonold and Fromme 2014).  This elaborate network of interactions serves to coordinate 
the multitude membrane trafficking events in the endomembrane system, and at the Golgi in 
particular. 
 
Roles and Regulation of Golgi Rab GTPases         
Rab GTPases are essential for the maintenance of the Golgi as a dynamic organelle (Kim et al. 
2016).  Two main sets of Rabs function at opposite ends of the Golgi: yeast Ypt1 (matched by 
several isoforms of Rab1 in humans) and the homologous pair Ypt31/32 (Rab11) (Figure 1.4 A) 
(Barr 2009).  An additional Rab, Ypt6 (Rab6), coordinates vesicle traffic from the endosome to 
the TGN (S. Siniossoglou and Pelham 2001; Symeon Siniossoglou, Peak-Chew, and Pelham 
2000; Bensen, Yeung, and Payne 2001; Suda et al. 2013).  After vesicles leave the Golgi complex, 
the Rab GTPase Sec4 (Rab8A/8B/10/1) is responsible for shuttling them to the plasma membrane 
(Ortiz et al. 2002; Mizuno-Yamasaki, Rivera-Molina, and Novick 2012).  A number of human 
diseases have been linked Golgi Rabs and their regulators and effectors, including neurological 
disorders, cancer, and infectious diseases, highlighting the critical role that these GTPases play 
(E. E. Kelly et al. 2012). 
 
Ypt1 is most well-known for its role in targeting COPII vesicles to the cis-Golgi, where it 
interacts with the tether Uso1 (Figure 1.4 A) (Jedd et al. 1995; Bacon et al. 1989; Segev, 
Mulholland, and Botstein 1988).  However, it has been implicated in many trafficking steps, 
including endocytic recycling, recruitment of Arf-GEFs to the Golgi, intra-Golgi trafficking 
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Figure 1.4.  Rab and Arf GTPases in Golgi membrane trafficking.  (A) Rab GTPases and Rab-
GEFs at the Golgi complex.  (B) Arf family GTPases and the large Golgi Arf-GEFs.  Yeast 
proteins are labeled.  Arf1 represents yeast Arf1 and Arf2.  Human homologs: Ypt1, Rab1; 
Ypt31/32, Rab11, Ypt6, Rab6; Arl3, ARFRP1; Gea1/2, GBF1; Sec7, BIG1/2/3. 
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(through interactions with the conserved oligomeric Golgi [COG] complex), and 
autophagosome formation (Figure 1.4 A) (Sclafani et al. 2010; McDonold and Fromme 2014; 
Lynch-Day et al. 2010; Cai, Reinisch, and Ferro-Novick 2007; Smith and Lupashin 2008). 
 
Nucleotide exchange on Ypt1 is catalyzed by the Rab-GEF complex transport protein particle III 
(TRAPPIII) at both the Golgi and in its role at autophagosomes (article in progress, Fromme 
lab).  GTP hydrolysis is stimulated by the Rab-GAP GAP for Ypt1 (Gyp1) (Du and Novick 
2001). 
 
Ypt31/32 represent a genetically redundant pair in yeast and localize mainly to the TGN (Figure 
1.4 A), whereas their human homolog, Rab11, localizes to recycling endosomes, which have not 
been found in yeast (Benli et al. 1996; Ullrich et al. 1996).  Ypt31/32 stimulate nucleotide 
exchange activity of the Arf-GEF Sec7 and also participate in TGN to plasma membrane traffic 
by recruiting the Sec4 GEF, Sec2, to secretory vesicles (McDonold and Fromme 2014; Ortiz et al. 
2002).  Ypt31/32 are activated by the Rab-GEF complex TRAPPII, which shares its core subunits 
with TRAPPIII but is distinguished by several unique subunits (Thomas and Fromme 2016).  
Gyp2 has been proposed as a Rab-GAP for Ypt31/32 based on genetic interactions (Sciorra et al. 
2005).  Ypt31/32 have also been implicated in a Rab-GAP cascade, recruiting Gyp1 to inactive 
Ypt1 at the late Golgi (Rivera-Molina and Novick 2009).  In this way, Ypt1 and Ypt31/32 define 
and differentiate Golgi compartments across their overlapping territories (Kim et al. 2016). 
 
Arf GTPases in Membrane Trafficking         
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The Arf family of GTPases includes both true Arfs and Sar1, which is included in the family due 
to structural (myristoylated amphipathic helix) and functional (coat protein recruitment) 
similarities (Gillingham and Munro 2007b).  The Arf GTPases are grouped into three classes 
based on closest sequence homology.  Class I Arfs (Arf1/2 in yeast, Arf1-3 in humans) are found 
throughout eukaryotes and function in membrane trafficking (Figure 1.4 B).  Class II Arfs 
(Arf4/5 in humans) are found only in higher eukaryotes, where they a proposed to play 
specialized roles in Golgi trafficking.  Class III Arfs (Arf3 in yeast, Arf6 in humans) localize to 
the plasma membrane and to endosomes, where they function in endocytic trafficking and 
cytoskeleton remodeling (D’Souza-Schorey and Chavrier 2006; Donaldson and Jackson 2011; 
Gillingham and Munro 2007b). 
 
Other members of the Arf family include a host of Arf-related proteins (Arls), which are 
structural similar to Arf but lack ADP-ribosylation activity (Gillingham and Munro 2007b).  
Yeast claim three Arl GTPases: Arl1, Arl3, and Cin4 (human Arl2).  Cin4 plays a non-essential 
role in β-tubulin folding, while Arl1 and Arl3 are involved in membrane trafficking at the TGN 
(Bhamidipati, Lewis, and Cowan 2000).  Arl3 (human ARFRP1) regulates the pathway leading 
to activation of Arl1, which in turn interacts with golgin-97, RabBP2α, Imh1p, and p230 (GRIP) 
domain golgin protein Imh1 and the Golgi-associated retrograde protein (GARP) complex to 
tether endosomal vesicles at the TGN (Figure 1.4 B) (Panic, Whyte, and Munro 2003; Setty et al. 
2003).  Arl1 also interacts with Golgi Arf-GEFs (Figure 1.4 B) (McDonold and Fromme 2014; Tsai 
et al. 2013). 
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The true Arf GTPases are activated by the Sec7 family of GEFs, which share a highly conserved 
catalytic GEF domain (originally termed the Sec7 domain, after its discovery in the first 
identified member of the family).  The Sec7 family GEF domain consists of 10 alpha helices and 
induces a conformational change on Arf which forces GDP release (Goldberg 1998).  The GEF 
for Sar1, Sec12, has no Sec7 domain (Gillingham and Munro 2007b).  Yeast possess three 
members of the BIG/GBF subfamily (Gea1/2 and Sec7), one member of the PH and Sec7 domain 
(PSD)/EFA6 subfamily (Yel1), and one member of the brefeldin A-resistant Arf-GEFs 
(BRAG)/IQSEC7 subfamily (Syt1), but lack members of the cytohesin and FBXO8 subfamilies 
(Gillingham and Munro 2007b; Casanova 2007; Donaldson and Jackson 2011).  Yel1 catalyzes 
nucleotide exchange on Arf3 at the plasma membrane, while Syt1 activates Arl1 at the TGN (K.-
Y. Chen et al. 2010; Donaldson and Jackson 2011). 
 
Sec7 family Arf-GEFs diverge widely in their regulatory domains (Figure 1.5) (Casanova 2007).  
The EFA6, cytohesin, and BRAG subfamilies all contain domains with homology to domains of 
known function, including coiled coil (CC) domains and membrane-targeting pleckstrin 
homology (PH) domains (C. L. Jackson and Casanova 2000).  Even an uncharacterized 
subfamily, FBXO8, contains a conserved F-box domain, known to mediate interactions with 
ubiquitin ligases in other proteins.  Only the Golgi Arf-GEFs, Sec7/BIG and Gea/GBF1, lack 
domains homologous to any outside their own subfamily, suggesting specialized regulation at 
the Golgi complex (Casanova 2007; Anders and Jürgens 2008). 
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Figure 1.5. Comparison of the domains of Sec7 family Arf-GEFs.  Domain diagram comparing 
the domains of Sec7 family GEFs found in humans and yeast. 
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There are 10 families of Arf-GAPs, though most are not represented in yeast (Kahn et al. 2008).  
Arf-GAP function is achieved through a conserved GAP domain including a catalytically-
required zinc finger motif containing four cysteines and an arginine residue (Kahn et al. 2008).  
The Arf-GAPs identified in yeast thus far are Age1, Age2, Gcs1, Glo3, and Gts1.  Many of the 
yeast Arf-GAPs seem to play overlapping roles: no single yeast Arf-GAP is essential, although 
simultaneous deletion of Gcs1 and Age2 is lethal (Poon et al. 2001).  Gcs1, Glo3, Age1, and Age2 
are all able to stimulate GTPase activity of Arf1 (Poon et al. 1999; Poon et al. 1996; Poon et al. 
2001; Zhang et al. 2003).  Gcs1 can also act on Arl1, while Gts1 displays activity on Arf3 at the 
plasma membrane (Smaczynska-de Rooij, Costa, and Ayscough 2008; Liu et al. 2005).  Glo3, the 
yeast ortholog of human ArfGAP2/3, has been shown to participate in retrograde trafficking by 
COPI vesicles from the Golgi to the ER; it has been identified on COPI vesicles (Lewis et al. 
2004; Poon et al. 1999).  GTP hydrolysis by Arf1 has been shown to be required for uncoating of 
COPI vesicles (Tanigawa et al. 1993). 
 
The Arf GTPases may have less diverse roles than Rabs in the secretory pathway, but they are 
central regulators of essential events: coat recruitment and membrane deformation.  Upon 
activation by its GEF, Sec12, Sar1 interacts directly with Sec23 to recruit the Sec23/24 cargo 
adaptor and initiate COPII vesicle coat oligomerization (Barlowe et al. 1994; Bi, Corpina, and 
Goldberg 2002).  Effectors of the redundant pair Arf1 and Arf2 at the Golgi include COPI, AP-1, 
GGA, and exomer, identifying Arf1/2 as a lynchpin regulator in both anterograde and 
retrograde Golgi trafficking (Paczkowski et al. 2012; Donaldson and Jackson 2011; Dell’Angelica 
et al. 2000; S. Y. Park and Guo 2014).  Arf1, Arf3 (Arf6 in humans), and Sar1 have all been 
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implicated in the induction of membrane curvature (Krauss et al. 2008; Lee and Pohajdak 2000; 
Lundmark et al. 2008).  As they hold the keys to vesicle coating and budding, Arf GTPases 
represent regulatory focal points for the secretory pathway.  The GEFs which activate Arf 
GTPases are therefore crucial decision-makers in membrane trafficking, particularly at the Golgi 
complex. 
 
 
Regulation of the Golgi Arf-GEFs         
The Sec7/BIG and Gea/GBF1 Arf-GEFs are considerably larger than the rest of their family 
members, between 160-200 kD.  The BIG subfamily includes yeast Sec7, the founding member 
of the Sec7 family, and BIG1/2/3 in humans, although BIG3 is thought to lack catalytic GEF 
activity (Casanova 2007).  The Gea/GBF1 subfamily includes Gea1 and Gea2 in yeast and GBF1 
in humans (Bui, Golinelli-Cohen, and Jackson 2009).  Unlike other members of the Sec7 family, 
the Golgi Arf-GEFs are sensitive to the drug brefeldin A (BFA), which locks the GEF-Arf 
complex in the GDP-bound state and causes gross disruption of Golgi morphology (Wood, 
Park, and Brown 1991; Lippincott-Schwartz et al. 1991; Sata et al. 1998; Peyroche et al. 1999).  
The importance of the roles the Golgi Arf-GEFs play is highlighted by mutation in BIG2 which 
have been linked to neurological disorders (Sheen et al. 2004; De Wit et al. 2009).  
 
Both Sec7/BIG and Gea/GBF1 subfamilies contain six predicted conserved domains, with an 
additional domain found in the Sec7/BIG subfamily (Figure 1.5) (Bui, Golinelli-Cohen, and 
Jackson 2009).  The N-terminal dimerization and cyclophilin binding (DCB) domain was 
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described in the plant Gea/GBF1 Arf-GEF, GNOM, as facilitating dimerization and binding to 
cyclophilin 5 (Grebe et al. 2000), although the functional importance of dimerization and 
conservation of the cyclophilin 5 interaction have not been reported.  Immediately C-terminal to 
the DCB domain is the homology upstream of Sec7 (HUS) domain, which our group recently 
showed to fold as a single domain with the DCB domain in Thielavia terrestris Sec7 (DCB/HUS) 
(Richardson et al. 2016).  In addition, we showed that this joint DCB/HUS domain in Sec7 
facilitates membrane insertion of the Arf1 amphipathic helix upon nucleotide exchange. 
 
The catalytic GEF domain follows the DCB/HUS domain and is in turn followed by three more, 
the homology downstream of Sec7 (HDS1, HDS2, and HDS3) domains.  It should be noted that 
these domains show no homology to one another, but rather each domain is conserved across 
species.  Comprehensive roles for these domains remain unclear, despite recent advances.  Our 
group showed that the C-terminal domains of Sec7 regulate catalytic function through 
autoinhibition and that HDS1 domain interacts with Arf1-GTP in a positive feedback loop 
(Richardson, McDonold, and Fromme 2012).  The HDS1 domain of GBF1 has been implicated in 
targeting to lipid droplets and the Golgi membrane (Bouvet et al. 2013), but this role has not 
been tested for conservation in yeast.  Finally, the Sec7/BIG Arf-GEFs have an additional 
domain, HDS4, which is not conserved among Gea/GBF1 Arf-GEFs.  We recently described a 
novel role for this domain in dimerization of yeast Sec7 (Richardson et al. 2016). 
 
Sec7/BIG function at the trans-Golgi network to facilitate anterograde traffic, while Gea/GBF1 
function in intra-Golgi and Golgi-ER retrograde traffic.  Therefore, understanding the 
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mechanisms which regulate localization of these Arf-GEFs to distinct parts of the Golgi is 
essential to understanding overall regulation of Arf1-initiated vesicle trafficking.  Our group 
demonstrated that several small GTPases, Arf1, Ypt1, Arl1, and Ypt31/32, cooperate to recruit 
Sec7 to Golgi membranes and stimulate its activity (McDonold and Fromme 2014).  Other Arf-
GEFs are regulated by equally complex interaction networks (Stalder and Antonny 2013).  
While a similarly fine-tuned coordination of signals is likely to recruit Gea1 and Gea2 to early 
and medial Golgi membranes, recruiting interactions have remained elusive.   
 
A direct interaction between the N-terminus of GBF1 and the human Ypt1 homolog, Rab1b, has 
been reported, but no functional significance for this interaction has previously been described 
(Monetta et al. 2007).  The trans-Golgi lipid flippase Drs2 and the small GTPase Arl1 have been 
identified as Gea interactors, although the reason for these interactions is unresolved (Chantalat 
et al. 2004; Tsai et al. 2013).  Similarly, no mechanistic explanation has been uncovered for the 
interaction between Gea2 and Gmh1, a Golgi protein of unknown function (Chantalat et al. 
2003), and the reported interaction between Gea/GBF1 and the COPI coat seems likely to occur 
downstream of Gea/GBF1 membrane recruitment (Deng et al. 2009).  In addition, many of these 
studies rely on yeast two-hybrid experiments with truncated proteins, which may be prone to 
artefacts, and none report in vitro mechanistic studies with completely purified full length 
Gea/GBF1. 
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Summary of presented work          
Here I will present my contributions to our understanding of the regulation of Gea1 and Gea2.  
First, I will share a completed story which describes the different membrane preferences of 
Gea1/2 and Sec7, the role of the HDS1-3 domains, and Gea recruitment by Ypt1 in a C-terminal 
dependent manner.  I will then outline my efforts to crystallize and solve the structure of Gea.  
Next, I will share further evidence of the roles of the domains of Gea1 and Gea2, as well as 
demonstrate that Gea1 and Gea2 occupy distinct Golgi compartments.  I will also describe my 
strategies for uncovering Gea interactors, culminating in the discovery of a potential new 
recruiting partner.  Finally, I will summarize future directions for this line of inquiry.   
Throughout, I will make the case that understanding the regulation of Gea1 and Gea2 will 
provide insight into the essential role that these proteins play and may offer evidence of 
conserved mechanisms for the regulation of membrane trafficking. 
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- CHAPTER 2 - 
REGULATION OF ARF ACTIVATION OCCURS VIA DISTINCT MECHANISMS AT 
EARLY AND LATE GOLGI COMPARTMENTS 
 
Introduction             
 
Intracellular membrane trafficking is an essential and intricately coordinated process in 
eukaryotes.  Membrane-bound vesicles transport synthesized proteins and lipids to 
compartments where modifications occur, deliver them to their final destinations, and shuttle 
them between organelles and the plasma membrane as needed.  The Golgi complex is the 
central sorting compartment for intracellular membrane trafficking, and vesicular traffic out of 
the Golgi is both tightly regulated and highly conserved to ensure that cargo only leaves the 
Golgi at the appropriate place and time. 
 
A key regulator of vesicle formation throughout the Golgi is the small GTPase Arf1 and its 
paralogs (Stearns et al. 1990; Donaldson and Honda 2005).  As with other small GTPases, Arf1 
functions as a molecular switch. When GDP-bound, it is inactive and cytoplasmic.  Upon GTP 
binding, Arf1 inserts its myristoylated N-terminal amphipathic helix into the membrane and 
changes conformation to recruit cargos, cargo adapters, and coat proteins to generate a vesicle 
(Bruno Antonny et al. 1997; Goldberg 1998).  Thus, the decision to switch Arf1 “on” through 
nucleotide exchange is a pivotal regulatory event in Golgi membrane trafficking. 
 
Nucleotide exchange on Arf1 is carried out by the Sec7 family of guanine nucleotide exchange 
factors (Arf-GEFs) (C. L. Jackson and Casanova 2000; Gillingham and Munro 2007a; Casanova 
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2007).  Two highly conserved subfamilies of Arf-GEFs function at the Golgi complex: Gea/GBF 
and Sec7/BIG, in Saccharomyces cerevisiae/humans, respectively (Achstetter et al. 1988; Peyroche, 
Paris, and Jackson 1996).  Outside of the highly-conserved catalytic GEF domain, these Golgi 
Arf-GEFs differ greatly from the rest of the Sec7 family to which they belong (Mouratou et al. 
2005; Bui, Golinelli-Cohen, and Jackson 2009).  They are considerably larger and share no 
sequence homology with any known domains in other proteins, including canonical membrane-
targeting domains, outside of the GEF domain.  Yet understanding how these Golgi Arf-GEFs 
are regulated and recruited to the correct membrane surface is essential to understanding the 
regulation of Arf1 activation and subsequent vesicle formation. 
 
The Sec7/BIG subfamily of Golgi Arf-GEFs functions at the TGN, activating Arf1 to form 
secretory vesicles and vesicles that traffic to endosomes and lysosomes.  Our group has shown 
that Sec7 is regulated through strong autoinhibition, a positive feedback loop with Arf1, 
interactions with several other small GTPases, and dimerization through its C-terminal HDS4 
domain (Richardson, McDonold, and Fromme 2012; Richardson et al. 2016; McDonold and 
Fromme 2014).  Sec7, Gea1, and Gea2 share predicted domain architecture (Bui, Golinelli-
Cohen, and Jackson 2009), which suggests shared regulation.  However, Gea1 and Gea2, which 
function in intra-Golgi and Golgi-ER retrograde traffic, lack similar positive feedback and 
dimerization regulatory mechanisms (Richardson, McDonold, and Fromme 2012).  Evidence of 
protein interactors has been presented by other groups (Jones et al. 1999; Chantalat et al. 2003; 
Chantalat et al. 2004; Monetta et al. 2007; Deng et al. 2009; Christis and Munro 2012; Tsai et al. 
2013), but to date no clear picture of the regulation of Gea/GBF has been established. 
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 Here, we present evidence for a model in which the C-terminal domains of Gea1 and Gea2 
serve both inhibitory and stimulatory functions in regulation.  We also show that the nature of 
the membrane surface is important for function of Gea1 and Gea2 and that the Rab GTPase Ypt1 
recruits Gea1 and Gea2 to membranes in a manner dependent on the C-terminus of Gea2.  Our 
findings define several important mechanistic differences between the Sec7/BIG and Gea/GBF1 
families and indicate that Arf1-dependent trafficking can be regulated independently at early 
versus late Golgi compartments. 
 
 
Results             
Gea1 and Gea2 localize differently relative to early and late Golgi markers.     
Sec7 is well-established as localizing to the TGN, where it activates Arf1 to initiate formation of 
secretory vesicles and vesicles that traffic to endosomes and the lysosome/vacuole.  In contrast, 
Gea1 and Gea2 have been shown to function in COPI vesicle-mediated intra-Golgi and Golgi-
ER traffic and to fractionate with early Golgi markers (Spang et al. 2001; Deng et al. 2009).  To 
confirm the distribution of large Arf-GEFs at the Golgi in live cells, we generated strains that co-
expressed endogenously-tagged Gea1 or Gea2 with either the early Golgi marker Vrg4 or with 
Sec7 as a marker for the TGN (Losev et al. 2006; Matsuura-Tokita et al. 2006).  Gea1 shows 
greater colocalization with Vrg4-labeled Golgi compartments (Figure 2.1 A) than with Sec7 
compartments (Figure 2.1, B & E), while Gea2 colocalizes more with Sec7 (Figure 2.1 C) than 
Vrg4 (Figure 2. 1, D & F).  Neither Gea1 nor Gea2 shows perfect colocalization or anti-
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Figure 2.1. Gea1 and Gea2 localize differently relative to early and late Golgi markers.  (A) 
Subcellular localization of GFP-Vrg4, an early Golgi marker, and Gea1-3xmRFPmars and (B) of 
Gea1-mNeonGreen and mRFPmars-Sec7, a late Golgi marker.  (C) Subcellular localization of 
GFP-Vrg4 and Gea2-3xmRFPmars and (D) of Gea2-mNeonGreen and mRFPmars-Sec7.  
Quantification of colocalization of Gea1 (E) or Gea2 (F) with Vrg4 or Sec7 at puncta.  Error bars 
represent 95% CIs for n = 76 (Gea1 v. Vrg4), n = 84 (Gea1 v. Sec7) cells, n = 59 (Gea2 v. Vrg4), or 
n = 58 (Gea2 v. Sec7) cells.  In all Merge panels, the GFP channel is shown in green, the RFP 
channel in magenta, and areas of overlap in white.  Differential interference contrast (DIC) 
panels show cells in the field.  **, P < 0.01; ***, P < 0.0001. 
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correlation with either marker, suggesting that the Gea Arf-GEFs occupy intermediate or hybrid 
compartments and reflecting the dynamic nature of the Golgi.  These data indicate that Gea1 
occupies earlier Golgi compartments than Gea2 (Figure 2.2A), hinting at differences in their 
roles and regulatory mechanisms. 
 
The in vitro membrane preferences of Gea1, Gea2, and Sec7 correspond to their sub-Golgi 
localization in vivo.            
One feature that distinguishes the early Golgi from the TGN is the net charge of the cytosolic 
membrane surface.  There is a well-established gradient of anionic phosphatidylserine (PS) 
across the secretory pathway, with very little PS exposed to the cytosol at the ER and as much 
as 10% or more PS in the cytosolic lipid content of the PM (Figure 2.2A) (van Meer, Voelker, and 
Feigenson 2008; Leventis and Grinstein 2010; Bigay and Antonny 2012).  This gradient is 
achieved by lipid flippases including Drs2, which flips PS from the lumen to the cytosol at the 
TGN (Natarajan et al. 2004).  Additionally, the phosphatidylinositol 4-kinase Pik1 
phosphorylates phosphatidylinositol (PI) to PI4P at the TGN (Walch-Solimena and Novick 1999; 
Strahl et al. 2005).  Both PI4P and PS lend negative charges to the membrane surface of the TGN 
which are absent at earlier Golgi compartments.  I hypothesized that the nature of the lipid 
environment in which each of the Golgi Arf-GEFs functions would impact their regulation, so I 
tested the membrane preferences of each Arf-GEF using in vitro catalytic assays. 
 
To measure the catalytic activity of Arf-GEFs, I employed a well-established assay which 
measures native tryptophan fluorescence of Arf1 to monitor GEF-catalyzed nucleotide exchange 
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Figure 2.2. The in vitro membrane preferences of Gea1, Gea2, and Sec7 correspond to their 
sub-Golgi localization in vivo.  (A) Cartoon of the secretory pathway, showing relative sub-
Golgi localization of Gea1, Gea2, and Sec7 as well as the gradient of anionic lipids on the 
cytosolic membrane surface from the ER to the plasma membrane.  Representative normalized 
traces showing activation of Arf1 by Sec7f (B), Gea1 (D), and Gea2 (F) on synthetic PC and TGN 
liposomes.  Rates of Arf1 activation determined from full sets of traces for Sec7f (C), Gea1 (E), 
and Gea2 (G).  Error bars represent 95% CIs for n = 3 reactions.  *, P < 0.05; **, P < 0.01. 
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in real time (Higashijima et al. 1987; Richardson and Fromme 2015).  These experiments were 
performed at approximate physiological concentrations of GEF (100 nM) and Arf1 (600 nM) 
(Ghaemmaghami et al. 2003) in the presence of artificial liposomes. 
 
As we reported previously, our group has purified a functional recombinant construct of Sec7 
(Sec7f) for use in in vitro studies (Richardson, McDonold, and Fromme 2012; McDonold and 
Fromme 2014).  Similar biochemical studies of Gea1 and Gea2 have been precluded by the 
difficulty in purifying stable Arf-GEFs in sufficient quantities for study.  Therefore, we 
established protocols for purifying full length recombinant Gea1 and Gea2, allowing us to make 
biochemical inquiries into the mechanisms of Gea1 and Gea2 regulation (Figure 2.3 A). 
 
We benefit from a detailed model for TGN lipid composition (Klemm et al. 2009; Richardson, 
McDonold, and Fromme 2012), which we used to generate liposomes that mimic the TGN’s 
lipid environment.  We lack similar data describing the precise lipid composition of the earlier 
Golgi compartments, so we used a simplistic model of neutral phosphotidylcholine (PC) to 
simulate the lipid environment of the early Golgi. 
 
When we measured catalysis of Arf1 activation by Sec7, we observed a 10-fold higher rate on 
TGN than on PC liposomes (Figure 2.2, B & C).  This parallels the inherent preference of Arf1 
for TGN liposomes when intrinsic exchange was stimulated by incubation with EDTA (Figure 
2.4) and matches the known localization of Sec7 to the anionic TGN.  Notably, Gea1 and Gea2 
both display the opposite preference: Gea1 demonstrated a 3-fold and Gea2 a 2-fold higher rate 
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 Figure 2.3.  GEF constructs used for biochemistry are pure and His6 tags were successfully 
cleaved.  (A) After purification from Escherichia coli, equal masses of full length Gea1 and Gea2, 
Gea2ΔHDS3, Gea2ΔC, and Gea2GEF were separated on an 8% polyacrylamide gel and 
visualized by Coomassie staining.  Western blots with anti-His antibody against (B) Gea2 before 
TEV cleavage of the His6 tag and final reagent samples of Gea1 and Gea2, (C) Gea2ΔC before 
and after TEV cleavage of the His6 tag, as well as the final Gea2ΔC reagent, and (D) dilutions of 
fractions of Gea2GEF pooled after TEV cleavage, after incubation with and elution from Ni-
NTA resin, and the final Gea2GEF reagent.  For all western blots, Ponceau stains reveal protein 
on the membrane. Note that TEV protease is His6-tagged. 
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Figure 2.4.  EDTA-induced Arf1 nucleotide exchange favors TGN over PC liposomes in vitro.  
(A) Normalized traces showing EDTA exchange of Arf1 on PC, PC-Ni2+, TGN, and TGN-Ni2+ 
liposomes.  (B) Rates of Arf1 exchange determined from traces in (A). 
 
 
  
35
of Arf1 exchange on PC over TGN liposomes (Figure 2.2, D-G).  This is contrary to the intrinsic 
preference of Arf1, indicating that the Gea GEFs themselves prefer PC over TGN lipids.  This 
finding is consistent with the localization of Gea1 and Gea2 to earlier Golgi compartments, 
which lack exposed anionic lipids such as PS and PI4P. 
 
Cells require a critical mass of either Gea1 or Gea2 for growth.      
Gea1 and Gea2 are genetically redundant under normal growth conditions (Peyroche, Paris, 
and Jackson 1996).  However, although an arf1Δgea1Δ mutant (sustained by wild type Arf2, 
which is expressed at 10-fold lower cellular concentrations than Arf1 (Stearns et al. 1990)) is 
viable, an arf1Δgea2Δ is not (Spang et al. 2001).  One possible explanation for this phenotype is 
some separation of function between Gea1 and Gea2, with Gea2 serving a function that is 
essential under stress conditions.  Another possibility is a simple difference in expression levels: 
Gea2 is expressed at approximately 5-fold higher levels than Gea1 (Ghaemmaghami et al. 2003).  
In light of our observation that Gea1 and Gea2 show different localization patterns, we tested 
the simpler of these two possibilities by creating promoter swaps to invert expression levels of 
the two Arf-GEFs. 
 
Using a plasmid shuffling strain (gea1Δgea2Δ) maintained by GEA2 on a URA3 plasmid, we 
compared LEU2 plasmids harboring GFP-tagged wild type GEA1 or GEA2 to the promoter 
swaps PGEA2-GEA1 and PGEA1-GEA2.  Western blotting of GFP-immunoprecipitation samples 
confirmed that the promoter swap had the expected effect, significantly reducing cellular 
expression levels of Gea2 (Figure 2.5 A). 
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Figure 2.5. Cells require a critical mass of either Gea1 or Gea2 for growth.  (A) Protein 
expression levels of Gea2 expressed through its endogenous promoter (Gea2) and through 
Gea1’s promoter (PGEA1-Gea2) were visualized by Western blot after GFP pull-downs.  G6PDH 
serves as a loading control.  (B) Gea1 and Gea2, expressed through their endogenous promoters 
or with swapped promoters, were expressed on CEN plasmids in gea1Δgea2Δ and 
gea1Δgea2Δarf1Δ cells and selected for with 5-FOA.  Relative growth of colonies on 5-FOA 
media reflects sufficiency of each construct to support growth as the sole early Arf-GEF in the 
cell.  (C) Cells from the top right panel of B were cultured and plated onto media containing 50 
ng/µl and 100 ng/µl Congo Red to test for sensitivity to this compound.  Data shown represent 
≥3 independent experiments. 
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 We observed that yeast growth was impaired in cells harboring only wild type Gea1, compared 
to only wild type Gea2 (Figure 2.5 B).  Yeast harboring the promoter-swapped PGEA2-Gea1 grew 
as well as those with wild type Gea2, while promoter swapped PGEA1-Gea2 yielded growth 
impairment similar to wild type Gea1 (Figure 2.5 B).  Furthermore, in a shuffling strain stressed 
by reduced levels of Arf at the Golgi (gea1Δgea2Δarf1Δ), the phenotype was more stark: cells 
harboring Gea1 or Gea2 expressed via the GEA2 promoter grew, while cells with the GEA1 
promoter-driven Gea1 or Gea2 constructs failed to grow. 
 
Another previously observed difference between Gea1 and Gea2 is the sensitivity of gea2Δ cells 
to Congo Red, a dye which interferes with cell wall integrity by binding nascent β-glucan 
chains.  gea2Δ cells, but not gea1Δ cells, are hypersensitive to Congo Red (Tsai et al. 2013), again 
suggesting some function of Gea2 that Gea1 cannot complement.  However, when we tested the 
promoter swap constructs, the Congo Red phenotype was revealed to also depend on 
expression levels (Figure 2.5 C).  Cells with only wild type Gea1 were more sensitive to Congo 
Red than cells with only wild type Gea2.  Cells harboring PGEA2-Gea1, on the other hand, grew as 
well as cells with wild type Gea2, while cells with PGEA1-Gea2 did not grow. 
 
These results demonstrate that the sensitivity of gea2Δ and survival of gea1Δ cells under stress 
conditions can be attributed to differential expression levels of Gea1 and Gea2, rather than to an 
essential function specific to Gea2.  It also highlights the requirement for a critical mass of either 
Gea1 or Gea2 under stress conditions. 
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 The HDS1 and HDS2 domains of Gea1 and Gea2 are required for localization and essential in 
vivo, while the HDS3 domain is dispensable .        
Studies of human GBF1 have revealed roles for its N-terminal domains in homodimerization 
and for its HDS1 domain in membrane targeting (Ramaen et al. 2007; Bhatt et al. 2016; Bouvet et 
al. 2013).  The roles of the HDS2 and HDS3 domains remain unresolved, and Gea1 and Gea2 
may have evolved separate regulatory mechanisms from GBF1 after the whole genome 
duplication event in yeast.  Therefore, we pursued more information regarding the roles of the 
C-terminal domains of Gea1 and Gea2. 
 
In addition to full length (FL) Gea1 (1-1408) and Gea2 (1-1459), we generated C-terminal 
truncations of Gea1 and Gea2 harboring C-terminal mNeonGreen tags: Gea1ΔHDS3 (1-1225), 
Gea1ΔC (1-774), Gea2ΔHDS3 (1-1234), and Gea2ΔC (1-782) (Figure 2.6 A).  We found that 
constructs lacking both the HDS2 and HDS3 domains were unstable.  The stable constructs 
were introduced into wild type yeast and expressed under the native GEA1 and GEA2 
promoters.  We verified by Western blotting that the truncations do not dramatically diminish 
expression levels under these conditions (Figure 2.6 B). 
 
Fluorescence microscopy revealed that, for both Gea1 and Gea2, the FL and ΔHDS3 constructs 
localized normally to Golgi puncta (Figure 2.6 C).  The ΔHDS3 signal was weaker than the FL, 
likely reflecting the slight reduction in expression shown in Figure 2.6 B.  Strikingly, Gea1ΔC 
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Figure 2.6.  The HDS1 and HDS2 domains of Gea1 and Gea2 are required for localization and 
essential in vivo, while the HDS3 domain is dispensable.  (A) Diagram of full length and 
truncated constructs of Gea1 and Gea2 employed in this study. DCB, dimerization and 
cyclophilin binding; HUS, homology upstream of Sec7; GEF, guanine nucleotide exchange 
factor (catalytic, aka “Sec7” domain); HDS, homology downstream of Sec7. Note that the HDS1, 
2, and 3 domains are not homologous to one another.  (B) Full length Gea2 (Gea2 FL), Gea2 
lacking the HDS3 domain (Gea2ΔHDS3), and Gea2 lacking all domains downstream of the GEF 
domain (Gea2ΔC) were expressed with GFP tags through Gea2’s endogenous promoter on CEN 
plasmids in wild type cells.  After pull-down with GFP, expression levels of each construct were 
assessed through Western blot.  *, signal from endogenous Gea2 in the whole cell extract before 
pull-downs.  G6PDH serves as a loading control.  (C) Gea1 and Gea2 constructs (FL, ΔHDS3, 
and ΔC) were tagged with 3xGFP and visualized in wild type cells.  DIC panels show cells in 
the field.  (D) The same constructs of Gea1 and Gea2 were expressed in gea1Δgea2Δ and 
gea1Δgea2Δarf1Δ cells as in Figure 3B.  Data shown represent ≥3 independent experiments.  
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and Gea2ΔC were completely mislocalized to the cytoplasm, showing no punctate signal 
despite expression comparable to that of the ΔHDS3 construct. 
 
We next tested the ability of these C-terminal truncations to provide essential Gea function and 
observed that for both Gea1 and Gea2, the FL and ΔHDS3 constructs supported growth in the 
gea1Δgea2Δ strain (Figure 2.6 D).  The growth of cells harboring only Gea1ΔC is considerably 
impaired, while cells harboring only Gea2ΔC do not grow at all.  As expected, none of the Gea1 
constructs supported growth in gea1Δgea2Δarf1Δ strain, while the relative growth of cells 
harboring the Gea2 truncation constructs remained the same. 
 
Together, these results indicate that the HDS3 domains of Gea1 and Gea2 are dispensable for 
subcellular localization and essential function.  In contrast the HDS1 and HDS2 domains are 
required for localization to Golgi cisternae and for cell survival. 
 
The C-terminus of Gea2 both inhibits membrane binding in vitro and contributes to Arf1 
nucleotide exchange.            
To try to understand the reason for mislocalization of Gea1ΔC and Gea2ΔC, we purified 
recombinant Gea2ΔC as well as a construct comprising the GEF domain of Gea2 (558-782) 
(Figure 2.6 A).  We then tested membrane binding of each construct in membrane pelleting 
assays (Paczkowski and Fromme 2016).  As PC liposomes do not pellet efficiently in this assay, 
we incubated each construct with TGN liposomes.  After subjecting each binding reaction to 
ultracentrifugation, we isolated the membrane pellet, including any membrane-associated 
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proteins, and quantified the amount of each Gea2 construct in the pellet and the supernatant by 
measuring band intensity after SDS PAGE.  We controlled for background pelleting of Gea2 by 
carrying out parallel experiments in the absence of liposomes (Figure 2.7 A).  After normalizing 
for background pelleting, we found about 15% of Gea2 FL bound to membranes (Figure 2.7 B).  
Unexpectedly, considering the in vivo results, Gea2ΔC showed higher affinity for membranes, 
with approximately 30% of that construct pelleting.  Finally, the Gea2GEF construct showed no 
affinity for membranes above background. 
 
As the C-terminal domains of Gea2 are essential in vivo but not required for membrane binding 
in vitro, we tested whether the C-terminus might play a role in the nucleotide exchange function 
of Gea2.  First, we tested Arf1 nucleotide exchange by Gea2 FL, Gea2ΔC, and Gea2GEF in the 
presence of PC liposomes.  Gea2FL and Gea2ΔC showed no significant difference in exchange 
rates on these liposomes, while the GEF domain displayed no measurable exchange activity 
(Figure 2.7 C).   
 
Considering the very slow rates of Arf1 activation observed on PC liposomes, we hoped to tease 
out subtle differences in activity by observing reactions under different conditions.  We have 
observed that Gea1 and Gea2 show a significant preference for liposomes containing the 
artificial lipid Ni2+-DOGS, used in assaying potential recruiting interactions with poly-histidine-
anchored proteins. Despite lacking histidine tags (Figure 2.3, B-D), full length Gea1 and Gea2 
display higher reaction rates on PC-Ni2+ liposomes than on PC liposomes, and Arf1 itself shows 
a subtle preference for PC-Ni2+ over PC liposomes when activated by EDTA (Figure 2.4).  A 
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Figure 2.7. The C-terminus of Gea2 both inhibits membrane binding and contributes to Arf1 
nucleotide exchange.  (A) Purified full length Gea2 (Gea2 FL), Gea2 lacking its C-terminal 
domains (Gea2ΔC), and the isolated catalytic domain (Gea2GEF) were incubated with or 
without TGN liposomes before ultracentrifugation.  Supernatant (S) and pellet (P) were 
separated and lipids and proteins in each fraction were visualized by SDS PAGE.  (B) 
Quantification of band intensity represented as percent Gea2 in pellet after subtracting 
background, for n = 3 (Gea2FL and Gea2ΔC) and n = 2 (Gea2GEF) independent assays.  Rates of 
Arf1 activation by Gea2 FL, Gea2ΔC, and Gea2GEF on PC (C) or PC-Ni2+ (D) liposomes or in the 
absence of liposomes using the soluble mutant Arf1ΔN17 (E).  n = 3.  n.d., not detectable (the 
Arf1 was not activated by the GEF, and exponential functions could not be fit to experimental 
curves); n.s., not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001. 
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similar affinity for Ni2+-DOGS lipids has been observed previously for other GEFs (Thomas and 
Fromme 2016).  While we lack a physiological explanation for the phenomenon, we reasoned 
that faster rates overall would amplify differences in catalytic rates.  Therefore, we tested the 
catalytic activity of Gea2ΔC and Gea2GEF on PC-Ni2+ liposomes. 
 
Interestingly, Gea2ΔC catalyzed exchange on Arf1 at a higher rate than Gea2 FL on PC-Ni2+ 
liposomes (Figure 2.7 D).  The GEF domain remained inefficient at catalysis in the absence of 
Gea2’s other domains, but catalyzed low level, measurable exchange on PC-Ni2+ liposomes.  
These relative exchange reaction rates correlated with the relative membrane affinities of these 
constructs (Figure 2.7, A and B). 
 
To examine how the C-terminus contributes to catalysis without the confounding factor of 
membrane interaction, we employed the mutant Arf1ΔN17, which is missing its amphipathic 
membrane-inserting helix and can therefore be activated in solution.  Based on the results in 
Figures 5, C and D, we expected one of two outcomes when testing Arf1 exchange by Gea2 
constructs in solution.  If the difference in rates observed on membranes was due to an allosteric 
effect of removing the HDS domains, the activity of Gea2ΔC would be higher than the activity 
of Gea2 FL in solution.  If the increased catalytic activity of Gea2ΔC was due to its increased 
membrane binding, and therefore higher likelihood of successful catalytic events, then Gea2ΔC 
and Gea2 FL would activate Arf1 at similar rates in solution.  Surprisingly, a third possibility 
proved true for this experiment: in these soluble exchange reactions, Gea2 FL showed the 
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highest catalytic rate on Arf1ΔN17, followed by Gea2GEF (Figure 2.7 E).  Gea2ΔC showed the 
slowest catalytic rate on Arf1ΔN17 in the absence of liposomes. 
 
Taken together, the results of these membrane binding and catalytic assays suggest a complex 
role for the C-terminus of Gea2 in regulating activation of Arf1, but show a clear role for the N-
terminus in membrane binding. 
 
Gea1 and Gea2 are recruited to membranes by the small GTPase Ypt1.     
As shown in Figure 2.7 A, approximately 15% of Gea2 FL is membrane bound in vitro in the 
absence of other factors.  Furthermore, in vivo, both N-terminal and C-terminal domains of Gea1 
and Gea2 are needed for Golgi localization.  This suggests that the intrinsic membrane affinity 
of Gea1 and Gea2 is likely not the only factor regulating their recruitment to Golgi membranes.  
Sec7 has been shown to be recruited to membranes and is regulated by interactions with several 
GTPases, so an analogous mechanism may regulate Gea1 and Gea2.  Although Gea1 lacks the 
positive feedback interaction observed between Sec7 and Arf1 (Richardson, McDonold, and 
Fromme 2012), the Arf-like GTPase Arl1 interacts with Gea2 (Tsai et al. 2013) and human Rab1b 
(yeast Ypt1) GTPase interacts with the N-terminus of human GBF1 (yeast Gea1/Gea2) (Monetta 
et al. 2007). 
 
To explore physical regulatory interactions between Golgi GTPases and Gea1/2, we carried out 
Gea1 and Gea2 membrane binding assays on PC-Ni2+ liposomes preloaded with activated (GTP-
bound) myristoylated Arf1, myristoylated Arl1, Ypt1-His7, or the Rab GTPase Ypt6-His7.  These 
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assays confirmed that Arf1 does not recruit either Gea1 or Gea2 to membranes (Figure 2.8, A 
and B).  Furthermore, neither Arl1 nor Ypt6 increased membrane binding of Gea1 or Gea2 
(Figure 2.9).  The only Golgi small GTPase that increased membrane binding was Ypt1. 
 
We hypothesized that this recruitment of Gea1 and Gea2 to membranes by Ypt1 would increase 
their catalytic rates on Arf1 by concentrating the GEFs at the membrane surface where 
activation of Arf1 must occur.  To test this hypothesis, we performed catalytic assays using 
liposomes alone, liposomes preloaded with activated Arf1, and liposomes preloaded with 
activated Ypt1-His7.  As expected from the membrane binding results, Arf1 conferred no 
improvement of catalytic activity for Gea1 or Gea2 (Figure 2.8, C & D).  Surprisingly, 
recruitment by Ypt1 under these conditions yielded only a subtle increase in catalytic rate for 
Gea1 and a statistically insignificant increase for Gea2.  To dissect this apparent discrepancy 
between our expectations and results, we halved the concentration of liposomes in the catalytic 
assays.  If recruitment is important for activity, increasing the scarcity of membranes in the 
reaction should resolve a difference between intrinsic, weak membrane binding of Gea1 or Gea2 
and active recruitment by Ypt1.  Indeed, in catalytic assays with reduced liposome 
concentrations, both Gea1 and Gea2 showed higher catalytic rates on Ypt1-preloaded liposomes 
compared to liposomes alone (Figure 2.8, E & F). 
 
These results indicate that Ypt1 increases Gea1 and Gea2 GEF activity by increasing membrane 
recruitment of the GEF, thereby increasing the likelihood of productive catalytic interactions 
between the GEF and Arf1 at the membrane surface. 
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Figure 2.8.  Gea1 and Gea2 are recruited to membranes by the small GTPase Ypt1. Membrane 
pelleting assays as in Figure 5 including preloaded small GTPases.  Graphs show percent of 
Gea1 (A) or Gea2 (B) bound to membranes after incubation with PC-Ni2+ liposomes alone, 
preloaded with Arf1-GTP, or preloaded with Ypt1-His7-GTP.  n = 3.  Rates of Arf1 activation by 
Gea1 (C) and Gea2 (D) on 333 µM PC-Ni2+ liposomes alone, preloaded with Arf1-GTP, or 
preloaded with Ypt1-His7-GTP.  n = 3.  Rates of Arf1 activation by Gea1 (E) and Gea2 (F) with 
166 µM PC-Ni2+ liposomes alone or preloaded with Ypt1-His7-GTP.  n = 3.  n.s., not significant; *, 
P < 0.05; **, P < 0.01.  
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Figure 2.9.  Neither Arl1 nor Ypt6 recruits Gea1 or Gea2 to membranes.  Purified Gea1 and 
Gea2 were incubated with or without PC-Ni2+ liposomes and with no recruiter or GTP-bound 
Arf1, Arl1, Ypt1-His7, or Ypt6-His7 before ultracentrifugation.  Supernatant (S) and pellet (P) 
were separated and proteins in each fraction were visualized by SDS PAGE. 
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 The C-terminus of Gea2 is required for recruitment by Ypt1.      
Finally, we set out to understand how regulation by the domains of Gea2 is coordinated with 
regulation through recruitment by Ypt1.  To add a further degree of biological relevance, we 
carried out these assays using recombinant prenylated Ypt1 (prenyl-Ypt1).  We used a protocol 
for purifying and modifying Ypt1 in vitro, yielding a complex of prenyl-Ypt1 and its stabilizing 
protein, GDP Dissociation Inhibitor (GDI) (Thomas and Fromme 2016).  Using prenyl-Ypt1 
enabled us to test Gea2 membrane binding and catalytic activity on membranes without any 
confounding effect from Ni2+-DOGS. 
 
First, we observed that prenyl-Ypt1 can recruit Gea2 FL to TGN liposomes (Figure 2.10 A).  
While the increase in membrane binding was more subtle with prenyl-Ypt1 and TGN liposomes 
than with Ypt1-His7 and PC-Ni2+ liposomes, the trend endured under the more physiological 
conditions.  Despite the documented interaction between Rab1b and GBF1’s N-terminus 
(Monetta et al. 2007), prenyl-Ypt1 did not increase membrane binding of Gea2ΔC on TGN 
liposomes (Figure 2.10 B).  The observed slight reduction in membrane binding of Gea2ΔC may 
reflect crowding of the membrane surface by prenyl-Ypt1 that cannot effectively recruit the 
truncated GEF.  This result indicates that the C-terminal domains of Gea2 are required to 
stabilize the Ypt1-Gea2 interaction on membranes. 
 
We next tested whether the failure of prenyl-Ypt1 to recruit Gea2ΔC to membranes coincided 
with an inability to improve catalytic activity.  Gea2 FL showed an approximately 2-fold 
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Figure 2.10.  The C-terminus of Gea2 is required for recruitment by Ypt1.  Percent of Gea2 FL 
(A) or Gea2ΔC (B) in membrane pellet after incubation with either TGN liposomes alone or 
with prenylated Ypt1-GTP (prenyl-Ypt1).  n ≥ 3.  Rates of Arf1 activation by Gea2 FL (C) or 
Gea2ΔC (D) on PC liposomes alone or preloaded with prenylated Ypt1-GTP.  n = 3.  n.s., not 
significant; *, P < 0.05; **, P < 0.01.   
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increase in catalytic rate on PC liposomes preloaded with prenyl-Ypt1 (Figure 2.10 C), similar to 
that observed on PC-Ni2+ liposomes preloaded with Ypt1-His7 (Figure 2.8 F).  However, Gea2ΔC 
catalyzed Arf1 exchange at nearly the same rate on PC liposomes alone as on PC liposomes 
preloaded with prenyl-Ypt1 (Figure 2.10 D), indicating that the C-terminus of Gea2 is required 
for effective membrane recruitment by Ypt1, as well as for the positive effect on catalysis 
conferred by Ypt1 recruitment. 
 
 
Discussion             
Arf1 and its homologs are the central coordinators for Golgi vesicle formation in eukaryotic 
cells, where cargos are sorted for transport to the plasma membrane, the lysosome, and the 
endosome, as well as for retrograde traffic within the Golgi and to the ER.  Thus, the activation 
of Arf GTPases at the Golgi represents a critical and conserved point for regulation of Golgi 
membrane trafficking.  In yeast, the activation of Arf1/2 is carried out at the late Golgi by Sec7 
and at earlier Golgi compartments by Gea1 and Gea2, implicating these Arf-GEFs as the key 
decision-makers in initiation of vesicle formation at the Golgi.  Despite the essential role of Gea1 
and Gea2 in retrograde transport, the mechanisms that govern regulation of these Arf-GEFs 
have remained elusive. 
 
We have relatively little structural information about these large proteins, beyond structures of 
the GEF domain (Renault et al. 2002) and of a portion of the N-terminus of Thielavia terrestris 
Sec7 (Richardson et al. 2016), leaving any structure/function clues in the C-terminus obscured.  
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Temperature sensitive mutants have proven useful in describing whole-Golgi or whole cell 
phenotypes for Gea1 and Gea2 mutations (Spang et al. 2001; S.-K. Park, Hartnell, and Jackson 
2005), but the precise reasons for these phenotypes are difficult to infer.  Descriptions of genetic 
and physical interactions with Ypt1/Rab1b, COPI coat proteins, Drs2, Arl1, and Gmh1 allude to 
the complex environment in which Gea/GBF function (Jones et al. 1999; Chantalat et al. 2003; 
Chantalat et al. 2004; Monetta et al. 2007; Deng et al. 2009; Christis and Munro 2012; Tsai et al. 
2013), but fail to separate recruiting from effector interactions, leaving the order of events of 
these interactions and the identity of recruiting partners unknown.  The question of how these 
interactions fit into the overall tasks of Golgi membrane trafficking is unclear, and an exact 
picture of detailed regulatory mechanisms for Gea/GBF recruitment and function has yet to 
emerge. 
 
In this study, we demonstrate that Gea1 and Gea2 share their essential function and several 
regulatory features (Figure 2.11 A).  We show that while the HDS3 domain of Gea1 and Gea2 is 
dispensable for both localization and function in vivo, the HDS1 and HDS2 domains are 
required for localization.  Our findings also reveal that the C-terminus of Gea2 is required for 
the interaction between Gea2 and Ypt1, which recruits Gea2 to membranes in vitro. Together 
with a previously reported role for the GBF1 HDS1 domain in targeting to lipid droplets 
(Bouvet et al. 2013), our results indicate a general role of the C-terminal domains in organelle 
targeting. 
 
52
 
Figure 2.11.  Model of Gea regulation.  (A) Assignment of functions and interactions to 
domains of Gea1/Gea2.  Membrane binding and the behavior of the C-terminus of Gea1/Gea2 in 
the absence (B) and presence (C) of active recruiting interactions.  Note that the membrane 
diagramed represents a neutral membrane, lacking anionic lipids.  Grey (?) represents a 
potential interactor which confers specificity of localization to Gea1 and Gea2. 
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Our colocalization studies show Gea1 and Gea2 to have different colocalization patterns relative 
to the early and late Golgi markers Vrg4 and Sec7.  This is consistent with a model in which 
Gea1 and Gea2 occupy intermediate compartments within the Golgi, overlapping at cis and 
trans compartments with Vrg4 and Sec7.  This model posits a continuum of Arf-GEFs across the 
Golgi (Figure 2A) and is consistent with evidence that GBF1 (Gea1/Gea2) provides the seed Arf-
GTP to recruit BIG1/BIG2 (Sec7) to the TGN (Richardson, McDonold, and Fromme 2012; 
Lowery et al. 2013).  In addition, Gea1 occupies earlier Golgi compartments than Gea2, which 
must require distinct recruitment mechanisms and implies different roles for the two GEFs.  
Further study is needed to understand how and why Gea1 and Gea2 show different 
colocalization patterns. 
 
It appears that any specialized roles for Gea1 or Gea2 are not essential, however, as we show 
here that Gea1 and Gea2 are equally functional in stressed cells when expressed with the higher 
copy GEA2 promoter.  This confirms a redundant essential function and highlights the 
requirement for a critical cellular concentration of Gea under stress conditions. 
 
We observed that Gea1 and Gea2 display a preference for neutral over anionic membranes in 
catalytic assays.  Sec7, on the other hand, prefers anionic membranes.  These preferences 
correlate with the localization patterns of the GEFs, with Gea1 and Gea2 occupying earlier Golgi 
compartments than Sec7, which functions at the late Golgi.  Intriguingly, a recent study showed 
that recruitment of Caenorhabditis elegans GBF1 to membranes was reduced in an siRNA 
knockdown of the rate-limiting enzyme for PC synthesis (Smulan et al. 2016), suggesting a 
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physiological role for Golgi lipid composition in recruitment of GBF1/Gea family Arf-GEFs.  
Together with our previous observation that another late Golgi GEF, TRAPPII, prefers anionic 
membranes (Thomas and Fromme 2016), these results suggest a general mechanism for 
regulating the membrane specificity of Golgi GEFs.  As these GEFs lack traditional membrane 
binding domains, the increasing negative charge of the late Golgi and TGN may help exclude 
early Golgi GEFs and recruit late Golgi GEFs to the TGN. 
 
We found that the HDS3 domain of Gea1 and Gea2 is dispensable for in vivo localization to the 
Golgi and for the essential function of Gea.  In biochemical studies (not shown), we found that 
Gea2ΔHDS3 showed a milder version of each phenotype observed for Gea2ΔC.  Future 
investigations may reveal whether this conserved domain plays a regulatory role separate from 
the HDS1 and HDS2 domains.  
 
Unlike Sec7, whose C-terminal domains function in both strong catalytic autoinhibition and the 
protein interactions which relieve that autoinhibition, Gea1 and Gea2 are not catalytically 
autoinhibited.  Instead, we show here that the C-terminus of Gea2 inhibits membrane binding, 
perhaps by masking the intrinsic affinity of the Gea2 N-terminus for membranes.  Removal of 
the C-terminal domains of Gea2 increased both membrane binding and the rate of Arf1 
exchange on membranes, yet the C-terminus of Gea2 was required for Golgi localization and 
full exchange function in the absence of membranes.   
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Our results combine to evoke a model for carefully calibrated regulation of Gea2 by its C-
terminal domains: in the absence of active recruitment to membranes, the C-terminus functions 
to keep Gea2 in the cytosol (Figure 2.11 B).  Once this membrane-binding inhibition is relieved 
by active recruitment, the C-terminus switches functions to promote efficient catalysis of Arf1 
exchange (Figure 2.11 C). 
 
We have identified Ypt1 as one of the active recruiters for Gea1 and Gea2.  The functional 
importance of this interaction is underscored by the suppression of the gea1-6 temperature 
sensitive mutation by overexpression of Ypt1 (Jones et al. 1999).  Ypt1 recruits Gea1 and Gea2 to 
membranes in vitro, and this recruiting interaction requires the C-terminal domains, despite 
previous evidence of a direct interaction between the N-terminus of GBF1 and Rab1b (Figure 
2.11 C) (Monetta et al. 2007).  It is possible that the C-terminus stabilizes the interaction with 
Ypt1, or that intrinsic membrane binding in the HDS1 domain of Gea1 and Gea2 complements 
the Ypt1 recruitment.  As both the Ypt1 interaction and intrinsic membrane binding seem weak 
or transient, it is likely that concomitant interactions cooperate to fully recruit Gea1 and Gea2 to 
the membrane surface (Figure 2.11 C). 
 
Our results clearly distinguish the regulation of Gea1 and Gea2 from that of Sec7.  Gea1 and 
Gea2 do not participate in a positive feedback loop with Arf1 (Richardson, McDonold, and 
Fromme 2012); Arf1 cannot recruit either Gea1 or Gea2 to membranes and it does not stimulate 
GEF activity in vitro.  This characteristic represents an important regulatory divergence from 
Sec7, as does the absence of apparent catalytic autoinhibition and the failure of Arl1 to have a 
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recruiting or stimulating effect on Gea1 or Gea2, and the lack of autoinhibition resembles more 
distant members of the Sec7 family of Arf-GEFs, such as BRAG, which functions in endocytosis 
(Aizel et al. 2013).  Additionally, Gea1 and Gea2 lack a fourth C-terminal domain, HDS4, which 
is conserved within the Sec7/BIG subfamily.  We recently described the role of this domain in 
homodimerization of Sec7 (Richardson et al. 2016).  However, Gea2 is dimeric in the absence of 
the HDS4 domain, reinforcing previous observations that the N-terminal domains of Gea/GBF1 
are responsible for dimerization (Grebe et al. 2000; Ramaen et al. 2007; Bhatt et al. 2016) and 
further differentiating regulation of the early Golgi Arf-GEFs from that of the late. 
 
One regulatory feature that Gea1 and Gea2 share with Sec7 is the interaction with Ypt1.  Ypt1 
may serve as a general Golgi recruiter for Arf-GEFs.  However, the specific sub-Golgi 
localization of Gea1, Gea2, and Sec7 must require additional specific recruiting interactions for 
each Gea1 and Gea2, either with proteins or with the membrane surface (Figure 2.11 C).  Our 
results imply that membrane lipid character likely plays an important role in Golgi Arf-GEF 
targeting and GEF activity.  The comprehensive identification and characterization of protein-
protein and protein-membrane interactions will be crucial to a full understanding of how 
vesicular membrane trafficking at the Golgi is coordinated. 
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- CHAPTER 3 - 
IN PURSUIT OF A CRYSTAL STRUCTURE OF GEA 
 
Introduction             
 
As mentioned in Chapter 2, structural information about the large Golgi Arf-GEFs is relatively 
limited.  While we have crystal structures of the catalytic GEF domain of several family 
members and part of the N-terminus of Sec7 (Renault et al. 2002; Qiu et al. 2014; Richardson et 
al. 2016), how those domains relate to one another remains obscure, and we have no structure of 
the C-terminus nor an overall structure of these GEFs.  Such a structure would shed light on 
how the domains of the Golgi Arf-GEFs might interact to form tertiary or quaternary structures 
and could also reveal protein- or membrane-binding surfaces as targets for further study.  As it 
stands now, comprehensive scanning mutagenesis is challenging in such large proteins (160-200 
kD), so without a structure, we have been limited to studying the effects of a few temperature 
sensitive mutants and of large truncations.  With this in mind, I aimed to purify full length Gea1 
or Gea2.  After exhausting a number of approaches, the best crystals I grew yielded only low 
resolution diffraction data, but hint at an attainable structure for Gea1. 
 
 
Results             
Before my work, crystallization of Gea1 and Gea2 had been prohibited by the inability to 
produce sufficiently pure Gea.  While the E. coli purification protocol that we have established 
yields modest amounts of recombinant Gea1 and Gea2, they are sufficient, and more 
importantly, sufficiently pure, for crystallography.  I also applied our protocol to the 
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purification of shorter constructs that might illuminate relationships between domains (Table 
3.1). 
 
In light of the anticipated difficulty in crystallizing these proteins, I also identified and cloned 
homologs from additional yeast species, including thermophiles (Table 3.1).  The testing of 
homologous proteins for crystallography is a well-established approach for improving the 
likelihood of finding ideal conditions, and the thermophilic homologs in particular were chosen 
because they should be more stable and therefore more likely to form ordered crystals. 
 
Of all constructs tested, only Gea1 formed potentially useful crystals (Table 3.2).  Two 
constructs of Gea1, one full length with its histidine-tag cleaved and one lacking the first 14 
residues, formed crystals with rhomboid prism morphology under a number of conditions, all 
containing an acidic carbohydrate sodium salt (either trisodium citrate or sodium malonate).  
Full length Gea2 produced spherulites which failed to resolve into useful crystals through 
optimization, and the two thermophilic Geas tested for crystallization, from M. thermophila (Mt 
Gea) and C. thermophilum (Ct Gea), yielded no hits. 
 
I tested numerous cryoprotectant strategies to optimize diffraction (Table 3.3).  In addition to 
the gradual transfer of crystals into cryoprotectant solutions, I grew crystals in buffer containing 
cryoprotectant levels of DMSO before harvesting.  I also attempted growth in buffer containing 
cryoprotectant glycerol, which failed to produce crystals.  We collaborated with Q. Huang to 
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Construct Species Residues Notes
Gea1ΔHis-tag S. cerevisiae 1-1408 expresses worse than Gea2 (0.5-1 mg/8 L TB)
Gea2 S. cerevisiae 1-1459 expresses well (1-2 mg/8 L TB)
Gea1ΔHDS3 S. cerevisiae 1-1225 expresses poorly (0.5 mg/8 L TB)
Gea2ΔHDS3 S. cerevisiae 1-1196 expresses worse than Gea2 (0.5-1 mg/8 L TB)
Gea1ΔC+24 S. cerevisiae 1-777 failed to express stably
Gea2ΔC+24 S. cerevisiae 1-782 expresses worse than Gea2 (0.5-1 mg/8 L TB)
Gea2GEF S. cerevisiae 558-782 expresses very well; note that TEV cleaves well despite mis-cloned cleavage site
Gea1ΔN14 S. cerevisiae 15-1408 expresses well (1-1.5 mg/8 L TB)
Gea2ΔC50 S. cerevisiae 1-1409 expresses well (1 mg/8 L TB)
Gea C. thermophilum 1-1643 expresses well (1 mg/8 L TB)
Gea K. lactis 1-1397 expresses poorly (200 µg/8 L TB)
Gea K. thermotolerans 1-1399 expresses poorly (200 µg/8 L TB)
Gea M. thermophila 1-1400 expresses well (1-2 mg/8 L TB)
Gea Z. rouxii 1-1526 failed to express stably
Table 3.1. Constructs cloned and purified for crystallography.
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test a method developed at Cornell called high pressure cryocooling, which eliminates the need 
for cryoprotectants, but this technique proved fruitless for my crystals. 
 
I collected a 10 Å dataset of a Gea1ΔHis-tag crystal grown in 600 mM sodium malonate, 0.05 M 
HEPES pH 7.4, and 0.25% (v/v) jeffamine ED-2000 and cryoprotected in 700 mM sodium 
malonate, 50 mM HEPES pH 7.4, and 30% (v/v) glycerol (Figure 3.1).  Aside from the low 
resolution, I was unable to confidently index the crystal lattice indicating microscopic 
heterogeneity of the crystals.  None of the optimization strategies that I attempted after this 
dataset improved diffraction, as diffraction resolution from additional crystals frozen under 
different conditions approached 9.5 Å at best, still well short of useful resolution (Table 3.3). 
 
 
Discussion             
A full length structure of Gea1 or Gea2 remains a tantalizing objective, given the enormous 
advantage such information would provide in understanding how the structure of Gea relates 
to its function and regulation.  My own 10 Å dataset may prove useful in assessing alternate 
conformations of Gea by molecular replacement once a higher resolution structure is solved. 
 
Improving yields of Gea1 and Gea2 might permit more extravagant testing of obscure 
crystallization and cryoprotectant strategies.  It is noteworthy that neither Gea1 nor Gea2 
expressed in the Bac-to-Bac baculovirus expression system, but this approach may be worth 
74
 
 
Figure 3.1. Gea1 rhomboid prism crystals produce diffraction at 10 Å resolution.  (A) Gea1 
rhomboid prism crystals grown in Trisodium citrate and HEPES pH 7.4.  (B) The Gea1 crystal 
(#35) which yielded the dataset mounted on a loop for data collection.  This crystal was grown 
in 600 mM Sodium malonate, 0.05 M HEPES pH 7.4, 0.25% (v/v) Jeffamine ED-2000 and 
cryoprotected in 700 mM Sodium malonate, 50 mM HEPES pH 7.4, 30% (v/v) Glycerol.  (C) 
Diffraction pattern of the 10 Å dataset, which shows a relatively narrow field of scattering. 
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revisiting with different constructs to obtain greater yields of protein.  Overexpression and 
purification from yeast may also provide an avenue for improved yields, with optimization. 
 
Additional species may provide opportunities for crystallizing Gea homologs.  The sole Gea 
homolog in the thermophilic yeast T. terrestris (the species from which our N-terminal Sec7 
structure was solved (Richardson et al. 2016)) represented a challenge in cloning, as it contains 
four introns and one very short exon.  Renewed efforts at cloning this gene into a bacterial 
expression vector, either through improved PCR approaches or by generating cDNA, might 
supply a Gea construct more amenable to crystallization.  Beyond this, I did not test mammalian 
Gea homologs, which generally contain longer loops, nor homologs from common model 
organisms such as C. elegans, D. melanogaster, or A. thaliana.  Any of these species or others 
might deliver a successful Gea/GBF structure to a determined crystallographer. 
 
Last but not least, developments in the field of cryo-electron microscopy may provide an 
avenue for successfully solving a structure of Gea.  Gea1 and Gea2 reside near the low end of 
the size spectrum for cryo-EM, but optimization of sample preparation and the ever advancing 
technology in this approach bring us closer to a structure every day.  With a structure in hand, 
future researchers will have a powerful toolbox for asking and answering questions about Golgi 
recruitment, membrane- and protein- interactions, and autoregulation of the Golgi Arf-GEFs. 
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- CHAPTER 4 - 
THE DOMAINS OF GEA1 AND GEA2 REGULATE LOCALIZATION AND FUNCTION 
 
Introduction             
 
Gea1 and Gea2 are large proteins, but only one 200-residue domain out of 1400 amino acids is 
devoted to catalysis.  The remaining predicted domains likely regulate Gea in some way, either 
catalytically or by controlling Gea recruitment to membranes.  Without homologous domains in 
the literature or a solved protein structure, characterization of the relationship between the 
domains and regulation of Gea represents a challenge. 
 
Gross truncations of C-terminal domains have proven informative, as shown in Chapter 2.  
Dissecting how the structures and residues comprising those domains relate to their functions is 
more difficult.  Random mutagenesis has revealed temperature sensitive alleles of Gea1 and 
Gea2 (Peyroche, Paris, and Jackson 1996; S.-K. Park, Hartnell, and Jackson 2005), although the 
reason for phenotypes of these mutants is not always obvious.  Studies of mutants which 
impact domain interactions and membrane targeting have relied heavily upon yeast two-hybrid 
approaches which may be prone to artefacts (Bouvet et al. 2013; Ramaen et al. 2007).  More 
concrete information about the roles of domains and key amino acids of Gea1 and Gea2 is 
required to resolve a full picture of Gea regulation. 
 
Lastly, differences between Gea1 and Gea2 have rarely been addressed in the field.  We showed 
in Chapter 2 that main difference previously reported was an artefact of differences in 
expression levels between Gea1 and Gea2, but we also revealed that Gea1 and Gea2 do not 
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show identical colocalization patterns with Golgi markers.  Gea1 and Gea2 may represent in situ 
separation of function mutants for higher order eukaryotic Arf-GEFs like human GBF1, 
facilitating dissection of the tasks achieved by this Sec7 GEF subfamily. 
 
Results             
The HDS3 domain of Gea2 is a regulator of Gea2 membrane binding and catalytic activity.  
As shown in Figure 2.6, the HDS3 domain of Gea1 and Gea2 is dispensable for both the 
essential function of Gea1/2 and for localization to the Golgi.  As this domain is highly 
conserved across eukaryotes, we hypothesized that it might play a regulatory role, fine-tuning 
Gea localization or function.  Therefore, I purified Gea2ΔHDS3 for use in biochemical studies. 
 
When tested in membrane pelleting assays, Gea2ΔHDS3 bound membranes about two-fold 
better than Gea2 FL (Figure 4.1 A), an effect similar to that observed for Gea2ΔC in Figure 2.7 A.  
Interestingly, Gea2ΔHDS3 had a milder effect on the catalytic activity of Gea2 than Gea2ΔC, 
activating Arf1 significantly but subtly faster than Gea2 FL on membranes (Figure 4.1 B).  When 
activating Arf1 in solution, removing the HDS3 domain or the entire C-terminus had a similar 
effect on catalytic activity: both Gea2ΔHDS3 and Gea2ΔC show about half the catalytic rate of 
Gea2 FL when activating Arf1ΔN17.  The effect of removing the HDS1 and HDS2 domains is 
not additive with the removal of HDS3.  This suggests that whatever beneficial effect the C-
terminus has on catalysis of Arf1 exchange is conferred by the HDS3 domain.  Further 
investigation is required uncover the precise structural or functional role that this domain plays 
in Gea regulation. 
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Figure 4.1. The HDS3 domain opposes membrane binding but is required for full catalytic 
activity of Gea2 in vitro.  (A) Percent of Gea2 FL or Gea2ΔHDS3 in membrane pellet after 
incubation with either PC-Ni2+ liposomes.  n = 3.  Rates of Arf1 activation by Gea2 FL or 
Gea2ΔHDS3 on PC-Ni2+ liposomes (Arf1myr) or in solution (Arf1ΔN17).  Rates are shown relative 
to Gea2 FL for each experimental condition.  n = 3.  *, P < 0.05; **, P < 0.01; ***, P < 0.0001. 
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 An extra α-helix is required for stability of Gea1ΔC and Gea2ΔC.      
My early attempts to purify constructs of Gea1 and Gea2 truncated after the GEF domain failed, 
yielding no stably expressed protein and suggesting that our in vivo constructs were similarly 
unstable.  In reviewing secondary structure prediction maps of Gea1 and Gea2, I noticed a 
predicted 11-residue α-helix downstream of the GEF domain but before the unstructured loop 
leading to the HDS1 domain (Figure 4.2 A), which had been excluded from the previously 
predicted GEF domain sequence (Bui, Golinelli-Cohen, and Jackson 2009).  This helix, as well as 
the 12 residues preceding it, is perfectly conserved between Gea1 and Gea2, but not in GBF1 
(Figure 4.2 B).  Two more residues are well-conserved between Gea1 and Gea2 after the helix, 
beyond which the sequence conservation degenerates into a predicted loop.  I therefore 
designed Gea1ΔC and Gea2ΔC constructs with an additional 8 (included in reported structure 
of Gea2 GEF domain (Renault et al. 2002), excludes the helix) or 24 (including the helix) residues 
C-terminal to the GEF domain.  As demonstrated in Figure 2.6 B, the Gea2ΔC+8 construct 
expressed well in yeast cells.  The Gea2ΔC+24 construct purified relatively well from E. coli, 
allowing me to carry out the biochemical studies presented in Chapter 2.  Gea1ΔC+24 was not 
as stable in purification, which is not surprising, as Gea1 has consistently proven less amenable 
to purification than Gea2.  Further optimization of the Gea1ΔC construct or purification strategy 
may produce a stable version for biochemistry.  It is possible that the additional helix included 
in my constructs packs onto the GEF domain, stabilizing it when truncated, or that this 
sequence is important for folding.  Structural studies of this helix relative to the GEF domain 
may provide insight into the question of its biological importance. 
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Figure 4.2. Secondary structure predictions identify a previously undocumented α-helix C-
terminal to the GEF domain of Gea1 and Gea2.  (A) Predicted secondary structure map of 
Gea2 places an α-helix (green) after the reported GEF domain ends. (B) Sequence alignment of 
the C-terminus of the GEF domain in Gea1, Gea2, and human GBF1.  Previously described end 
of the GEF domain is marked with underlined italics, additional sequence conserved between 
Gea1 and Gea2 is marked in bold, and new predicted α-helix in Gea1 and Gea2 is marked in 
green, underlined bold. 
81
Reported point mutants represent an opportunity for isolating regulatory mechanisms. 
In combination with large scale truncations of domains, we turned to the analysis of the effects 
of point mutations to understand Gea1/2 regulation.  However, it is not trivial to identify 
potentially informative point mutants in 160 kD proteins with no known domain homology to 
proteins outside their family.  For such large proteins, or even the individual domains, 
traditional approaches such as comprehensive alanine scanning represent a considerable 
undertaking.  Therefore, we turned to mutations described in the literature to pursue 
biochemical mechanisms for cellular phenotypes (Table 4.1). 
A set of three point mutants in mammalian GBF1 was reported to disrupt dimerization through 
the DCB domain (Ramaen et al. 2007).  These results were obtained through yeast two-hybrid 
analysis of constructs of the DCB domain alone, either wild type or with each mutation.  Based 
on our 2016 structure of T. terrestris Sec7 DCB/HUS (Richardson et al. 2016), which showed that 
the DCB and HUS domains fold as a single domain, it is surprising that these constructs would 
be stable in cells.  While I successfully mapped these mutations onto Gea1 and Gea2 and cloned 
each construct individually, it seems likely that disruption of dimerization in full length Gea1 or 
Gea2 may require a combination of these mutations, so these mutants were not tested.  A 
combination of these mutations could provide a way to disrupt dimerization of Gea1 and Gea2, 
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Mutant Inspiration Purified? Experimental results
Gea1 K127A  ---  --- 
Gea1 D166A  ---  --- 
Gea1 D467A  ---  --- 
Gea2 K124A yes  Did not test
Gea2 D163A  ---  --- 
Gea2 D485A  ---  --- 
Gea1 W931S  ---  --- 
Gea2 W943S yes  No effect on membrane binding
Gea1 Y991C yes  Cannot replace Sec7 in vivo
Gea2 Y1001C yes  Cannot replace Sec7 in vivo
Bouvet et al, 2013
Arst Jr. et al, 2014
Ramaen et al, 2007
Table 4.1. Tests of reported point mutants.
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and further investigation of these mutants may offer mechanistic insight into the role of 
dimerization in regulation of Gea1/2. 
Membrane targeting of GBF1 to lipid droplets and the Golgi has been attributed to the HDS1 
domain (Bouvet et al. 2013).  A single amphipathic helix and an individual point mutant in that 
helix, W1028S, were identified as important for membrane binding.  I mapped this mutation 
into Gea1 and Gea2 and purified Gea2 W943S from E. coli, but observed no effect on membrane 
binding of Gea2 in our membrane pelleting assays (Table 4.1, data not shown). 
Finally, another intriguing mutant has been described which allows Gea/GBF to substitute for 
Sec7/BIG in vivo (Arst Jr. et al. 2014).  In this study, a single residue substitution, Y1022C, in the 
HDS1 domain of A. nidulans GeaA (Gea/GBF) was shown to suppress hypBΔ (Sec7/BIG), 
implicating this residue as a potential key to understanding regulatory differences between Gea 
and Sec7.  I mapped this mutation onto Gea1 and Gea2 and cloned each mutant into both 
bacterial and yeast expression vectors.  Ultimately, this fascinating phenotype is not conserved 
in S. cerevisiae: neither Gea1 Y991C nor Gea2 Y1001C could rescue the deletion of Sec7.  Gea1 
Y991C and Gea2 Y1001C were both purified, but I did not test them in biochemical assays.  In 
vitro studies could be revisited to ascertain whether these mutants cause any changes in the 
catalytic rate or lipid preferences of Gea1 and Gea2. 
Gea1 and Gea2 colocalize with different Golgi markers. 
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As Gea1 and Gea2 are genetically redundant, it could be assumed that they share sub-cellular 
localization.  In addition to the experiments presented in Figure 2.1, I attempted to colocalize 
Gea1 and Gea2 with additional Golgi markers.  Gea2 colocalized better than Gea1 with the 
Golgi marker Kex2, which cycles between the endosome and the TGN (Figure 4.3 A, C).  
However, Gea1 and Gea2 both show lower colocalization with the early Golgi marker Svp26 
(Figure 4.3 B, C), suggesting that Svp26 perhaps resides at a compartment which neither Gea1 
nor Gea2 fully occupies. 
Different localization of Gea1 and Gea2 is directed by the N-terminus of each. 
After observing that Gea1 and Gea2 show different patterns of colocalization with Golgi 
markers Figure 2.1, I wanted to measure how much Gea1 and Gea2 colocalize with one another.  
As a control, Gea2-Mars and Gea2-GFP colocalize well (Figure 4.4 A, B).  Surprisingly, Gea1 and 
Gea2 hardly ever colocalize, and this observation is confirmed by Pearson’s analysis. 
The collection of these data was complicated by the low abundance and fluorescent signal of 
Gea1.  Increasing exposure times to improve Gea1 signal left enough time for highly dynamic 
Golgi puncta to move between capturing each channel, hopelessly confounding the 
interpretation of colocalized puncta.  To overcome this problem, I collected these data using a 
dual-capture system, which allowed simultaneous imaging in both channels and eliminated 
issues with Golgi puncta moving during capturing.  However, there is some degree of signal 
bleed-through from the green channel into the red.  I corrected for this by measuring red 
channel signal intensity at puncta in a strain only expressing a GFP-fusion and subtracting that 
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Figure 4.3. Gea1 and Gea2 display different colocalization patterns.  Subcellular localization of 
Gea1-GFP and Gea2-GFP coexpressed with (A) Sec7-Mars, (B) Kex2-Mars, and (C) Svp26-Mars.  
(D) Quantification of colocalization of Gea1 or Gea2 with each marker at puncta.  Error bars
represent standard deviations for n = 45 (Gea1 v. Sec7), n = 16 (Gea2 v. Sec7), n = 51 (Gea1 v.
Kex2), n = 54 (Gea2 v. Kex2), n = 35 (Gea1 v. Svp26), and n = 51 (Gea2 v. Svp26) cells analyzed.
Yellow indicated overlap between channels.  Arrows indicate points of colocalization.  n.s., not
significant; ***, P < 0.0001.
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Figure 4.4. Differential localization of Gea1 and Gea2 is determined by their N-terminal 
domains.  (A) Subcellular localization of Gea2-Mars coexpressed with Gea2-GFP or Gea1-GFP.  
(B) Quantification of colocalization of Gea2 with Gea2 and Gea1 at puncta.  Error bars represent
95% confidence intervals for n = 79 (Gea2 v. Gea2) and n = 42 (Gea2 v. Gea1) cells analyzed. (C)
Subcellular localization of Gea2-Mars coexpressed with Gea1NGea2C-GFP or Gea2NGea1C-
GFP.  (D) Quantification of colocalization of Gea1 or Gea2 with each marker at puncta.  Error
bars represent standard deviations for n = 20 (Gea2 v. Gea1NGea2C) and n = 26 (Gea2 v.
Gea2NGea1C) cells analyzed.  Yellow indicated overlap between channels.  Arrows indicate
points of colocalization.  ***, P < 0.0001.  Data collection assisted by J.E. Manzi.
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value before carrying out channel math to calculate Pearson’s coefficients for these data.  
Nevertheless, this dataset should be considered preliminary, and follow-up experiments using 
brighter Gea tags, sequential channel imaging, and time-lapse imaging are warranted to 
confirm this result. 
After the observation that Gea1 and Gea2 occupy different Golgi compartments, I wanted to 
identify which domains in Gea1 and Gea2 are responsible for this difference.  I designed 
chimeras of Gea1 and Gea2 in which the C-terminus of Gea2 was fused with the N-terminus of 
Gea1 (Gea1NGea2C, and vice versa (Gea2NGea1C).  I chose the highly conserved 24-residue 
stretch immediately downstream of the GEF domain (shown in Figure 4.2) as the junction, to 
avoid amino acid changes that might prevent folding.  Working with J.E. Manzi, I cloned these 
constructs with GFP tags into yeast expression vectors.  First, we confirmed that these 
constructs are viable as the only copy of Gea in cells, as it was very possible that in creating the 
chimeras we would interfere with folding or domain-domain interactions.  Reassuringly, each 
chimera was able to support growth.  Yeast shuffled to contain only one chimera or the other 
grew in the same pattern as their respective N-terminal wild type cells, as each chimera was 
driven under the promoter that matched its N-terminus. 
Next, I compared the subcellular localization of each chimera to wild type Gea2-Mars.  We 
found that while Gea1NGea2C rarely colocalizes with wild type Gea2, Gea2NGea1C and wild 
type Gea2 frequently colocalize (Figure 4.4 C, D).  This result shows that the N-terminus is 
responsible for dictating the differential localization of Gea1 and Gea2.  It remains a formal, but 
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very unlikely, possibility that the observed localization arises through heterodimerization of the 
N-terminus of the chimera with the N-terminus of the endogenous protein.
J.E. Manzi began cloning and testing further N-terminal domain chimeras, but this work 
remains unfinished.  Additional experiments may pinpoint which N-terminal domain confers 
specific localization to Gea1 and Gea2, although such experiments may be confounded by 
protein instability if mutating the interface between the DCB and HUS domains disrupts 
folding or packing. 
Point chimeras represent divergence between Gea1 and Gea2 which may dictate localization 
specificity.  
To try to understand which residues in the N-terminus of Gea1/2 are important for localization, 
I worked with J.E. Manzi to identify residues in the N-termini of Gea1 and Gea2 which are 
highly conserved across the Gea/GBF family but at which either Gea1 or Gea2 diverges (Table 
4.2).  We prioritized residues in this category which represented dramatic differences between 
Gea1 and Gea2: charge inversions, large differences in side chain length, and differences in 
backbone rigidity.  We then designed single point chimeras in Gea1 and Gea2, and J.E. Manzi 
began to clone each into yeast expression vectors.  He successfully cloned one mutant (Gea2 
Q158K) and found that it could support growth as the only copy of Gea in the cell, but did not 
have time to test whether this mutant colocalizes with wild type Gea2.  The completion of 
cloning for the full set of chimeras, as well as some combinations, may provide a toolbox for 
isolating which residues are essential for the differential localization of Gea1 and Gea2.  If these 
89
Mutant Cloned? Experimental results
Gea1 V145H  ---  --- 
Gea2 H142V  ---  --- 
Gea1 K161Q  ---  --- 
Gea2 Q158K yes  No effect on cell growth in arf1Δ  background
Gea1 Q208R  ---  --- 
Gea2 R205Q  ---  --- 
Gea1 K215N  ---  --- 
Gea2 N212K  ---  --- 
Gea1 T315P  ---  --- 
Gea2 P330T  ---  --- 
Gea1 G322N  ---  --- 
Gea2 N337G  ---  --- 
Gea1 T338Y  ---  --- 
Gea2 Y353T  ---  --- 
Gea1 P409Q  ---  --- 
Gea2 Q424P  ---  --- 
Gea1 E482A  ---  --- 
Gea2 A500E  ---  --- 
Table 4.2. N-terminal reciprocal point chimeras in Gea1 and Gea2.
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residues can be isolated, the resulting mutants may be used in turn to help identify the 
recruiting interactions, either protein-protein or lipid-protein, which direct Gea1 and Gea2 to 
their separate Golgi compartments. 
 
Discussion             
Between the findings discussed in Chapter 2 and those presented here, we have developed a 
clearer picture of the roles played by the HDS domains of Gea1 and Gea2.  The C-terminus as a 
whole plays conflicting roles in different cellular environments.  When cytosolic, the C-terminus 
prevents inappropriate membrane binding by Gea.  Once actively recruited by protein binding, 
the C-terminus is required for optimal catalytic function.  Assigning these two roles to 
individual domains or even specific residues will require further investigation.  Indeed, as most 
all point mutants tested have caused no apparent effect in vitro, it is likely that overall domain 
interactions or surface patches are responsible for regulating Gea localization and activity.  A 
solved structure of the C-terminus of Gea will permit identification and study of such 
interactions or surfaces. 
 
Placing Gea1 and Gea2 spatially and temporally within the Golgi complex will provide useful 
context for understanding their roles and regulation, but has largely proven difficult due to the 
low expression levels (and low fluorescent signal) of the early Golgi Arf-GEFs, especially Gea1.  
We now have a brighter green fluorescent tag, mNeonGreen, which will enable more reliable 
colocalization experiments and quantification and hopefully allow us to develop a meticulous 
timeline of Gea Golgi recruitment.  Combining such studies with chimeras or deletion mutants 
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will reveal not only the different pathways in which Gea1 and Gea2 participate, but also the 
essential function in which they are redundant. 
Our finding that the specificity of Gea1 v. Gea2 recruitment is dictated by the N-terminus is 
especially interesting when compared with Figure 2.6 C, which shows that the N-terminus 
alone is insufficient to target Gea to Golgi membranes.  This suggests that a C-terminal 
interaction is required for recruitment to the Golgi, while an N-terminal interaction provides 
specificity between compartments.  It is also possible that the C-terminus is required to facilitate 
the specific N-terminal recruiting interactions, as I showed with the Ypt1 interaction in Figure 
2.10.  Perhaps the C-terminus provides structural interactions to improve geometry relative to 
the membrane surface, or stabilizes a weak interaction with protein recruiters.  Further 
investigation is required to resolve hypotheses into a model of Gea regulation by its domains 
and interacting partners. 
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- CHAPTER 5 - 
INTERACTING PARTNERS OF GEA1 AND GEA2 DIRECT LOCALIZATION 
 
Introduction             
 
In the absence of canonical membrane binding domains, Gea1 and Gea2 must rely on protein or 
membrane interactions for recruitment to the appropriate Golgi compartments.  While several 
protein interactions with Gea/GBF1 have been described (Jones et al. 1999; Monetta et al. 2007; 
Chantalat et al. 2003; Chantalat et al. 2004; Deng et al. 2009; Tsai et al. 2013), none have been 
shown to function as recruiting interactions.  Identification of the protein or lipid interactions 
which recruit Gea1 and Gea2 to the Golgi and specifically to different cisternae will permit 
mechanistic studies of Gea regulation and shed light on the different mechanisms which 
regulate anterograde and retrograde Golgi traffic. 
 
After employing both targeted and blind screens to discover new Gea interactors and testing 
reported interactions for in vitro recruitment, a complex model of recruitment has emerged for 
Gea1 and Gea2, requiring coordinated interactions.  In addition to the Ypt1 interaction 
documented in Chapter 2, we have uncovered novel potential recruiting partners: Golgi 
SNAREs.  Future investigations will focus on describing these interactions and dissecting the 
mechanism of Gea1 and Gea2 participation in different Golgi pathways. 
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Results             
No single Golgi protein tested is required for Gea localization.      
Sec7 is recruited by interactions with activated Arf1, Arl1, and Ypt1, and its activity is 
stimulated by Ypt31.  Considering the conservation between Sec7 and Gea1/2, we hypothesized 
that Gea would be recruited and regulated in a parallel manner, though possibly with different 
interacting partners.  Therefore, we carried out a targeted screen for mislocalization of Gea1 and 
Gea2 in a selected set of single deletion mutants, focusing on Golgi proteins which would be 
likely to encounter Gea1 and Gea2 (Table 5.1).  Minimally localized truncations lacking the 
HDS3 domain were used to increase the odds of identifying an essential recruiter.  
GEA1ΔHDS3-GFP and GEA2ΔHDS3-GFP were cloned into LEU2 CEN plasmids and 
transformed into each deletion strain.  Log phase cells were screened for loss of punctate Golgi 
signal. 
 
Most deletions failed to reveal an obvious mislocalization phenotype.  Subtle phenotypes 
(partial mislocalization) are difficult to perceive with certainty for Gea1 and Gea2, which show a 
constitutive pool of cytosolic signal.  Therefore, only a complete loss of punctate GFP signal 
qualifies as a sure phenotype.  Only deletion of Ypt6 or its GEF complex proteins, Rgp1 and 
Ric1, and a temperature sensitive mutant for the essential Ypt1 showed such loss of punctate 
signal.  However, when I sought to confirm these results by observing the localization of the 
Golgi marker Sys1-dsRed in ypt6Δ and ypt1-3 mutants, I found that Sys1 signal was no longer 
punctate, suggesting gross disruption of the Golgi complex (Table 5.1, data not shown).  It is 
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GEF-GFP Strain Phenotype
cog5Δ intermediate
cog6Δ intermediate
cog7Δ intermediate
cog8Δ intermediate
gyp8Δ intermediate
rgp1Δ mislocalized
ric1Δ mislocalized*
rud3Δ normal
vps51Δ intermediate
vps52Δ intermediate
vps53Δ normal
vps54Δ normal
arl1Δ normal
arl3Δ normal
arf1Δ normal
sys1Δ normal
syt1Δ normal
ypt31-101/ypt32∆ normal
ypt6Δ mislocalized*
ypt10Δ normal
ypt11∆ normal
ypt1-3 intermediate*
ypt6Δ mislocalized*
ypt1-3 intermediate*
drs2Δ normal
sgt2Δ normal
gyp1Δ normal
ypt10Δ normal
trs85Δ normal
trs86Δ normal
trs65Δ normal
ycp4Δ normal
smy1Δ normal
gyp2Δ normal
trs33Δ normal
syt1Δ normal
vps51Δ normal
vps52Δ normal
vps53Δ normal
vps53Δ normal
Gea2 FL and 
Gea2ΔHDS3
Gea1ΔHDS3
Table 5.1. Gea localization in single deletion strains.  *, Golgi disrupted.
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therefore impossible to know from these in vivo experiments whether Gea1 or Gea2 require Ypt1 
or Ypt6 for recruitment.  Further genetic analysis may provide insight into this question. 
 
Of the Golgi GTPases, only Ypt1 can increase the catalytic activity of Gea.    
In the absence of definitive data about possible recruitment of Gea1 or Gea2 by Golgi GTPases, I 
carried out a more focused target screen for an effect on membrane binding or catalytic activity 
of Gea1 and Gea2 in vitro.  Myristoylated Arf1 or Arl1 were preloaded onto membranes by 
incubation with excess GTP in the presence of PC-Ni2+ liposomes, and Ypt1-His7 and Ypt6-His7 
were membrane bound by their interaction Ni2+-DOGS and activated by incubation with GTP.  I 
measured the catalytic activity of Gea1 and Gea2 on PC-Ni2+ liposomes alone or with each of the 
small GTPases (Figure 5.1).  I observed that no small GTPase could increase Gea2 activity above 
mock, and that only Ypt1 could increase the activity of Gea1 significantly.  These results were 
probed further in the experiments documented in Chapter 2, Figures 6 and 7. 
 
Arl1 showed a statistically insignificant effect on the activity of Gea1 nearly as great as the effect 
of Ypt1, which may merit further investigation.  However, Arl1 does not increase Gea 
membrane binding in vitro (Figure 2.9), so this effect seems unlikely to represent a recruiting 
interaction.  The Ypt6 result may also bear further scrutiny, as our Ypt6-His7 construct purifies 
poorly for a small GTPase and seems less than perfectly stable in solution.  It should be noted 
that the Rab GTPase homologs Ypt31/32 were excluded from this screen because they are never 
seen to colocalize with Gea1 or Gea2 in fluorescence microscopy, so they seemed unlikely 
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Figure 5.1. Of the Golgi GTPases, only Ypt1 improves Arf1 activation by Gea.  Arf1 activation 
by Gea1 and Gea2 was measured in real time in the presence of PC-Ni2+ liposomes alone (Mock) 
or preloaded with Arf-GTP, Arl1-GTP, Ypt1-His7, or Ypt6-His7.  Rates are graphed relative to 
Mock.  All unmarked comparisons are n.s. (not significant).  *, P < 0.05. 
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recruiters.  The GTPase Arl3 was excluded because our lab has not purified it to date, but may 
be a good target for future testing. 
 
Conservation and molecular replacement were used to identify potential Ypt1-binding mutants 
of Gea2.             
It has been reported that human Rab1b (Ypt1) interacts with the N-terminus of GBF1 (Gea1/2).  
Therefore, we set out to identify highly conserved residues that might participate in that 
interaction in Gea2.  First, I generated a weblogo of the N-terminus of Gea2 (Figure 5.2 A), 
which displays highly conserved residues as larger letters.  From this weblogo, we selected 
residues which are both highly conserved and unlikely to be involved in helix stability or 
packed within the protein (hydrophobic).  These chosen clusters of residues were verified 
further by mapping onto a rough structural model of Gea2 based on T. terrestris Sec7 
(Richardson et al. 2016).  Conservation mapping on the model identified a few conserved 
patches, notably that surrounding YBmut4 (Figure 5.2 B). 
 
Mutants were cloned into a bacterial expression vector by Y.F. Chen, tested for expression, 
purified, and used in biochemical assays for membrane recruitment by Ypt1 (Table 5.2).  
Expression tests of each mutant showed expression in E. coli similar to wild type.  YBmut3 and 
YBmut4 were purified and tested for any effect on membrane recruitment by Ypt1, relative to 
wild type Gea2.  YBmut3 had no effect, while YBmut4 seemed have subtly reduced membrane 
recruitment by Ypt1.  Results were confounded by unusually high background membrane 
binding by both wild type and mutant Gea2, possibly due to issues with lipid stocks.  Despite 
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Figure 5.2. Sequence conservation and molecular replacement were used to predict possible 
Ypt1-binding residues in Gea2.  (A) Weblogo showing conservation of residues in the N-
terminus of Gea2.  Size of letters is proportionate to degree of conservation.  Planned mutations 
are boxed and labeled.  (B) A rough structural model of the N-terminus of Gea2 colored for 
conservation (red to blue, high to low conservation) was used to confirm that planned 
mutations were in likely surface residues and to identify conserved patches.  Conserved patch 
surrounding YBmut4 is emphasized here by space filled modeling of residues as an example. 
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Name Mutation Expression Experimental results
YBmut1 Gea2 E18A, C19A good  --- 
YBmut2 Gea2 R27A, K28A, K31A good  --- 
YBmut3 Gea2 K124A good
Reduced membrane binding?  
Pelleting expt a little suspect.  
Conflicting Arf1 activation results.
YBmut4 Gea2 T150A, H151A, C152A good No effect on membrane binding.
YBmut5 Gea2 R153A, F154A, E155A good  --- 
YBmut6 Gea2 D162A, D163A good  --- 
YBmut7 Gea2 N187A, S188A good  --- 
YBmut8 Gea2 Y191A, D192A good  --- 
YBmut9 Gea2 C202A, N203A good  --- 
YBmut10 Gea2 R205A, R206A, S207A, E208A good  --- 
YBmut11 Gea2 R211A, N212A, Q215A good  --- 
Table 5.2. Potential Ypt1 binding mutants.
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this, we tested YBmut4 for an effect on catalytic activity relative to wild type in the presence of 
Ypt1.  Across multiple sets of experiments, results are conflicting, possibly due to the same 
issues with lipid stocks or to issues with the fluorometer lamp.  Due to scheduling, not all 
constructs were purified and tested, and YBmut3 and YBmut4 have not been retested with new 
lipids and a new lamp.  As these mutants, especially YBmut4, have not been ruled out as 
affecting Ypt1 binding by Gea2, they may merit future investigation. 
 
Finally, Y.F. Chen also employed several temperature sensitive mutants of Gea1 and Gea2 in 
experiments to pursue additional in vivo phenotypes for these mutants which might reveal their 
mechanistic roles.  He observed that gea1-6, which carries two point mutations (L862S and 
F1135S) in the HDS1 and HDS2 domains, is partially mislocalized at restrictive temperature.  A 
rotation student who worked with me, A.M. Miller, attempted to purify gea1-6 for biochemical 
studies, but found it to be insoluble under normal Gea purification conditions.  Further 
optimization to purify this mutant will be required to allow biochemical analysis of its effect on 
Gea1.  A combination of additional in vivo and in vitro experiments may clarify both the 
molecular mechanism of the gea1-6 mutant and whether the Ypt1 interaction with this mutant is 
direct or indirect. 
 
Known Gea interactor Gmh1 fails to recruit Gea2 to membranes in vitro.     
As mentioned in Chapters 2 and 4, Ypt1 cannot be the only recruiting signal for Gea1 and Gea2, 
as Ypt1 also recruits Sec7, and all three Golgi Arf1-GEFs localize to different subcompartments.  
Therefore, we mined the literature for Gea interactors that might provide a recruiting effect.  
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The early Golgi protein Gmh1 was identified as a multicopy suppressor of gea1-6, and Gea1 and 
Gea2 were shown to coimmunoprecipitate with Gmh1 (Chantalat et al. 2003).  However, to date 
no function has been ascribed to Gmh1 and, as a multi-transmembrane domain protein, Gmh1 
is likely to be difficult to manipulate in vitro.  In addition to Gmh1, we postulated that another 
transmembrane Golgi protein of unknown function, Sft2, might be a Gea recruiter. 
 
The cytosolic tails of Gmh1 and Sft2 were cloned with His7 tags and purified by a rotation 
student who worked with me, D.J. Wasilko.  We then tested the ability of these cytosolic tails to 
recruit Gea2 or Gea2ΔHDS3 to PC-Ni2+ liposomes using a membrane pelleting assay.  We found 
that neither the cytosolic tail of Gmh1 nor that of Sft2 was able to recruit Gea2 or Gea2ΔHDS3 to 
membranes above the intrinsic membrane binding of Gea2 (Figure 5.3).  In fact, it seems likely 
that Gmh1 reduced membrane binding of Gea2 by crowding the liposome surface, preventing 
the native binding of Gea2 to the membrane.  Taken at face value, these results suggest that the 
reported interaction with Gmh1 occurs downstream of Gea2 recruitment and does not regulate 
Gea localization. 
 
However, we cannot definitively conclude from these experiments that Gmh1 and Sft2 are not 
recruiters of Gea1 or Gea2, as these cytosolic tail constructs are highly artificial.  They may lack 
the proper orientation or geometry relative to the membrane, or the interaction with Gea may 
occur in the loops between the transmembrane domains.  Further study of Gmh1 in particular, 
while non-trivial, may answer this question in a more biologically relevant manner.  
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Figure 5.3. The cytosolic tails of documented Gea2 interactors Gmh1 and Sft2 fail to recruit 
Gea2 to membranes in vitro.  Percent of Gea2 FL or Gea2ΔHDS3 in membrane pellet after 
incubation with either PC-Ni2+ liposomes alone or with His7-tagged cytosolic tails of Gmh1 (A) 
or Drs2 (B).  n = 3.  Data collected by D.J. Wasilko. 
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Nevertheless, we can safely conclude from these experiments that the sequence of the cytosolic 
tails of Gmh1 or Sft2 alone are insufficient to recruit Gea2 to membranes in vitro. 
 
SILAC-MS revealed Gea2 interactions with Golgi SNAREs.      
As targeted screens had failed to uncover the unique protein interactors which target Gea1 and 
Gea2 to different compartments, we chose to employ SILAC-MS to identify new interactions.  
We grew yeast with or without Gea2-HA in parallel cultures with light and heavy media, then 
formaldehyde crosslinked both cultures with low concentrations of formaldehyde (0.375%) to 
crosslink any interacting proteins.  After pulldown with HA and trypsin digestion, the samples 
were analyzed by mass spectrometry by D.S. Kim in the Smolka Lab.  Note that the low cellular 
levels of Gea1 have precluded collection of useful SILAC-MS data, despite efforts to scale up the 
cultures and preparations.  Further optimization of Gea1 SILAC-MS, perhaps by overexpression 
of Gea1, may prove valuable in the future. 
 
In addition to several other Golgi proteins, the top hits for Gea2 include two Golgi SNAREs: 
Gos1 and Sed5 (Figure 5.4 A).  A third interesting hit is the SM protein Sly1, which is known to 
interact with the Habc domains of certain SNAREs, such as Gos1 and Sed5, and regulate 
SNARE complex assembly (Kosodo et al. 2002).  Sed5 participates as the Qa in two SNARE 
complexes at the Golgi: one at the early Golgi receiving ER-Golgi vesicles and one at the medial 
Golgi receiving intra-Golgi and endosomal vesicles (Fasshauer et al. 1998; Hardwick and 
Pelham 1992; Volchuk et al. 2004).  Gos1 participates as the Qb in only the complex at the 
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Figure 5.4. Gea2 interacts directly with the Golgi SNARE Gos1 in vivo.  (A) Tops hits from 
SILAC-MS analysis with Gea2-HA as bait, sorted using a custom Z-score.  (B) Western blots of 
GFP-Gos1 IP using anti-GFP to detect Gos1 and anti-HA to detect HA-tagged Gea2.  GFP-Vrg4 
IP serves as a negative control.  Data collected by D.S. Kim, M.B. Smolka, and J.C. Fromme.   
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medial Golgi, making it an attractive prospect for the role of differentiating Gea1 and Gea2 
localization (McNew et al. 1998). 
 
An in vivo interaction between Gea2 and Gos1 was confirmed through co-immunoprecipitation 
of Gea2 in an IP of GFP-Gos1 (Figure 5.4 B).  Gea2 was pulled down specifically by Gos1 and 
not by another Golgi protein, Vrg4.  However, preliminary microscopy experiments showed 
that Gea2 is not mislocalized in a gos1Δ strain, indicating that the Gos1 interaction is not 
required for Gea2 recruitment to Golgi surfaces (data not shown). 
 
Gea1 colocalizes with early Golgi Bos1, Gea2 with medial Golgi Gos1.     
To test whether Gos1 is truly a specific interactor of Gea2 and not Gea1, we decided to test 
colocalization of Gea1 and Gea2 with both Gos1 and the early Golgi SNARE complex Qb 
SNARE, Bos1. When we co-expressed Gea1-3xMars or Gea2-3xMars with GFP-Gos1, we 
observed that Gea2 colocalized very well with Gos1, while Gea1 rarely did (Figure 5.5 A, B).  
Conversely, Gea1 colocalized very well with GFP-Bos1, while Gea2 showed no apparent 
colocalization with Bos1 (Figure 5.5 C, D). 
 
A caveat of these experiments is that the method for integrating the GFP-GOS1 and GFP-BOS1 
fusion genes introduces a second copy of each gene at the LEU2 locus and that second copy is 
driven by the high expression ACT1 promoter, so Gos1 and Bos1 are considerably 
overexpressed in these strains.  It was reported previously that overexpression of Gos1 in 
particular alters Golgi number and morphology (Losev et al. 2006), so it is possible that our data 
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Figure 5.5.  Colocalization patterns show that Gea2, but not Gea1, colocalizes with Gos1.  
Intracellular colocalization assessed by coexpression of RFP-labeled Gea1 (A, C) or Gea2 (B, D) 
with GFP-labeled Gos1 (A, B) or the early Golgi SNARE Bos1 (C, D).  Yellow indicates overlap 
of green and red channels.  Data collected by J.C. Fromme.    
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are confounded by this effect.  Further experiments to confirm these preliminary results are 
necessary. 
 
Purified Gos1 cytoplasmic domain is not monomeric, but can recruit Gea2 to membranes in 
vitro.              
To improve our understanding of the physical interaction between Gos1 and Gea2, and to 
ascertain whether Gos1 serves as a regulator of Gea2 or vice versa, I set out to purify Gos1 for 
biochemical studies.  We designed constructs encompassing the entire Gos1 cytoplasmic 
domain (1-204), the Gos1 Habc domains (1-129), and the Gos1 SNARE helix (130-20), each with 
a C-terminal His tag to replace the transmembrane domain, and introduced them into bacterial 
expression vectors.  The SNARE helix construct proved insoluble during purification, but I was 
able to purify both the cytoplasmic domain and the Habc domain with good yields. 
 
To test whether Gos1 is a membrane recruiter for Gea2, I carried out membrane pelleting assays 
with PC-Ni2+ liposomes and Gea2 alone or with Ypt1-GTP, Gos1 cytoplasmic domain, or Gos1 
Habc domain.  Interestingly, the Gos1 cytoplasmic domain recruited Gea2 to membranes as 
well as Ypt1, while the Habc domain did not increase membrane binding (Figure 5.6 A).  This 
preliminary results suggests that Gos1 can recruit Gea2 to membranes and that the SNARE 
helix is required for this recruitment. 
 
These results were somewhat confounded by the fact that Gos1 cytosolic tail fractionated into 
two distinct pools during gel filtration, one around the molecular weight of monomeric Gos1 
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Figure 5.6.  The purified cytoplasmic domain of Gos1 recruits Gea2 to membranes in vitro.  
(A) Percent of Gea2 FL in membrane pellet after incubation with either PC-Ni2+ liposomes alone 
(Gea2 only) or with Ypt1-His7-GTP, His-tagged Gos1 cytoplasmic (cyto) domain, or His-tagged 
Gos1 Habc domain.  n = 3.  (B, C) MALS analysis of two pools recovered from gel filtration of 
the purified Gos1 cytoplasmic domain of Gos1.  Error bars represent 95% confidence intervals.   
n.s., not significant; ***, P < 0.0001. MALS data collected by S.L. Halaby. 
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(Pool B) and one at a higher molecular weight (Pool A).  The pelleting data from Pool B is 
shown in Figure 5.6 A.  A comparison of the effect on pelleting of Pool A and Pool B shows that 
Pool A has a significantly smaller effect on Gea2 membrane binding than Pool B (data not 
shown).  To understand the nature of these two pools, each was analyzed by MALS to measure 
the molecular weight of proteins in solution. 
 
Interestingly, both pools of Gos1 cytosolic tail returned similar MALS data (Figure 5.6 B, C).  
Neither was monodispersed, as evident from the deviation of each molecular weight trace from 
a straight, horizontal line.  This deviation makes estimating molecular weight unreliable, but we 
can roughly estimate a range based on each trace.  Pool A returns a molecular weight range of 
about 80-100 kD if judged from the trace or 720 kD as calculated by the software.  This 
calculated value differs drastically from an obvious estimate based on the trace, likely due to the 
fact that the sample was not monodispersed.  Pool B returns a molecular weight range of about 
150-200 kD based on the trace or 150 kD as calculated by the software.  Regardless of the reason, 
all of these estimates are considerably higher than the approximately 25 kD molecular weight 
expected for a monomer of this construct.  These results suggest homo-multimerization and 
perhaps aggregation of the Gos1 cytoplasmic tail construct. 
 
It is telling that both pools recovered from gel filtration yielded similar traces from MALS 
analysis, despite the fact that Pool B should have a lower molecular weight as it eluted later 
from the gel filtration column.  This suggests that the equilibrium between monomeric and 
multimeric states favors multimers and that any monomer from Pool B disappeared into the 
110
mix of multimers observed by MALS.  It is notable that we also observed slightly larger than 
normal aggregation peaks in the MALS data, again hinting at the instability of this construct in 
solution. 
 
Before completing MALS analysis, I also prepared preliminary crystallization screens of the 
Gos1 cytosolic tail construct, but they failed to produce any hits, likely because the protein was 
not mono-dispersed in solution, but rather a mixture of monomers and various multimers. 
 
Further troubleshooting will be necessary to attain biologically relevant, stable SNAREs and 
SNARE complexes for use in biochemistry with Gea1 and Gea2. 
 
 
Discussion             
The evidently complex nature of regulating interactions and recruitment of Gea1 and Gea2 has 
complicated characterization.  Based on screens for mislocalization in single deletion strains, it 
seems plausible that no single interaction is either required or sufficient for Gea recruitment in 
vivo.  Instead, Gea1 and Gea2 may utilize coincidence detection in their decision-making process 
for activating Arf1.  In this model, Gea1 and Gea2 are recruited by weak or transient 
interactions with multiple factors.  While I cannot completely rule out the possibility that a 
single strong interaction might be required or sufficient to recruit Gea to the Golgi, we have 
been unable to uncover such an interaction, and our current evidence of protein and lipid 
interactions seems to point in the direction of cooperative recruitment. 
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Further characterization of the interaction between Gea and Ypt1 in vitro and in vivo, especially 
in concert with the recently discovered SNARE interaction, offers an opportunity for a thorough 
mechanistic model of both Gea recruitment and possible tethering to the membrane by its 
recruiting interactions, as well as exploration of conformation changes in Gea upon recruitment. 
 
The SILAC-MS hits of Golgi SNARE proteins present an intriguing line of inquiry.  While 
preliminary results are not without caveats, it is promising that the colocalization patterns of 
Gea1 and Gea2 are so distinctly opposite relative to Bos1 and Gos1; the difference is quite 
striking.  Further investigation is warranted to ascertain whether this difference persists with 
endogenous expression of the SNAREs and how the SNAREs themselves relate to one another, 
spatially or temporally, within the Golgi.  If the observation holds water, it should prompt 
additional tests for a direct interaction between Gea1 and Bos1, or other members of the early 
Golgi SNARE complex, and will bring us closer to an understanding of the different pathways 
in which Gea1 and Gea2 participate. 
 
We have begun efforts to improve purification of Gos1, as well as the other SNAREs of its 
complex, by using stabilizing protein fusions.  Additional measures, such as coexpression of the 
complex or expression with additional factors, such as the SM protein Sly1, may prove helpful 
in isolating stable SNARE complexes or monomeric SNAREs for further biochemical studies.  It 
seems likely that Gea2 interacts with at least a partially assembled SNARE bundle, in light of 
the fact that both Gos1 and Sed5 were identified in the SILAC-MS screen.  Developing the tools 
to test this and other hypotheses will allow us to form a detailed picture of the molecular 
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interactions between Gea2 and the SNAREs, as well as a broader understanding of the cellular 
context in which these interactions occur and their implications for coordination between 
incoming and outgoing Golgi vesicle traffic. 
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- CHAPTER 6 - 
FUTURE DIRECTIONS 
 
              
 
Both cellular and molecular models of Golgi Arf-GEF regulation emerge from this work.  Gea1, 
Gea2, and Sec7 each occupy different compartments within the Golgi, with Gea2 likely 
functioning later in the Golgi than Gea1.  This specificity is achieved through a combination of 
affinities for different membranes and protein interactions.  The regulatory domains of Gea1 
and Gea2 function differently from those of Sec7, as Gea1 and Gea2 show no catalytic 
autoinhibition or positive feedback.  The C-terminus of Gea functions in both masking 
membrane binding and facilitating catalysis, both the N- and C-termini are required for 
recruitment by the GTPase Ypt1, and the N-terminus is responsible for directing Gea1 and Gea2 
to different Golgi compartments.  A novel Gea2 interactor, the SNARE Gos1, presents a possible 
recruiter specific to Gea2, perhaps paralleled by recruitment of Gea1 by the early Golgi SNARE 
Bos1. 
 
Many of the details of this model remain unresolved.  The in vivo composition of the cis-Golgi 
has been difficult to measure, leaving the role of lipids in recruiting Gea somewhat undefined 
beyond “not anionic.”  While the preferences in vitro of each Golgi Arf-GEF seem to fit logically 
with their localization in vivo, further evidence will be required to prove once and for all that 
membrane identity plays a role in directing the Arf-GEFs. 
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The effect of positively charged artificial lipids is also striking.  It may represent an artefact, as 
there are no physiological positively charged lipids.  Preliminary studies by A.M. Joiner during 
his rotation and after showed that other artificial positive lipids had a similar or stronger effect 
on Gea recruitment to membranes and catalytic activity.  While this effect may be artefactual, its 
possible physiological interpretations are intriguing. 
 
One hypothesis we have considered attributes the membrane proximal positive charge to the 
di-lysine motif found in COPI cargos.  A.M. Joiner attempted anchor away experiments with the 
cytoplasmic tail of two COPI cargos used to lure Gea to the mitochondria, but he did not 
observe a change in Gea localization.  It is not unlikely that the greater concentration of COPI 
cargoes at the Golgi would confound a single di-lysine motif sent to the mitochondria, and 
other recruiting signals such as Ypt1 remained at the Golgi as well.  While this hypothesis is not 
trivial to test, it cannot be ruled out based on our experiments so far. 
 
Another tempting hypothesis points to the SNARE Gos1, which bears two membrane-proximal 
lysines as well as two arginines between its transmembrane and SNARE domains.  If Gos1 
proves to be a true recruiter of Gea2, this positively enriched motif might explain Gea2’s in vitro 
preference for Ni2+-containing liposomes. 
 
In terms of Gea regulation through its own domains, the next frontiers are domain- and residue-
level mechanisms.  Continuation of studies using conservation-selected mutants and chimeras 
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represent a potentially useful avenue for this work, but such studies may ultimately prove too 
simplistic to untangle the complex interactions regulating Gea. 
 
A full length structure of Gea, either solved through x-ray crystallography or cryo-EM, will 
provide a wealth of information for future dissection of atomic-level interactions which regulate 
Gea1 and Gea2.  Additionally, a structure of the GEF domain including the extra conserved 
helix may prove help explain why that helix has such a dramatic effect on the stability of 
Gea2ΔC. 
 
Our most promising current line of research revolves around the SNARE protein interactions 
discovered in our SILAC-MS experiments with Gea2.  Additional work is aimed at verifying 
whether this interaction is a recruiting interaction, and if so, whether Gea2 interacts with Gos1 
as a monomer, or with Gos1 and Sed5 as part of their assembled SNARE complex.  The 
implications of each hypothesis are fascinating.  If Gea2 is recruited by Gos1 alone, then Gea2 is 
recruited to the Golgi membrane surface before the arrival of incoming vesicles from 
endosomes.  If Gea2 interacts with the assembled Gos1/Sed5/Ykt6/Sft1 SNARE helix, this points 
to a very specific moment in the life cycle of those SNAREs: after vesicle fusion but before 
unzipping of the SNARE complex.  This hypothetical model suggests that the arrival of 
incoming vesicles with cargo may be coupled to preparations for packaging into COPI vesicles 
for retrograde transport, and that the interaction between Gea2 and the SNARE complex might 
mediate this coordination of events. 
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If Gea2 is recruited by Gos1, or the Gos1 SNARE complex, it is tempting to hypothesize that 
Gea1 may be recruited in a parallel manner by Bos1 or its SNARE complex.  So far our 
preliminary evidence for this hypothesis is the excellent colocalization of Gea1 with Bos1.  
Down the line, biochemical studies can be used to test the preferences of Gea1 and Gea2 for 
Gos1 and Bos1 in vitro.  This line of inquiry also raises interesting questions about the functional 
redundancy of Gea1 and Gea2.  If Gea1 is deleted, does Gea2 spread into Bos1 compartments to 
take up the tasks which Gea1 normally handles?  Can the opposite happen when Gea2 is 
deleted?  What function does Gea2 serve at the late Golgi, were it overlaps with Sec7?  Perhaps 
it relates to the interaction between Gea2 and Drs2, flipping of phosphatidylserine to help create 
the anionic lipid environment to which Sec7 is recruited.  In that vein, what is the source of the 
seed Arf1-GTP required for Sec7 positive feedback (Richardson, McDonold, and Fromme 2012)?  
Possibly Gea2 activates small amounts of Arf1 at the TGN to prepare the way for rapid 
secretory vesicle formation.  While these hypotheses are highly speculative, they focus on the 
way in which trafficking is orchestrated across the entire Golgi, rather than as distinct events.  
The more we learn about the recruitment and regulation of Gea1 and Gea2, the better we can 
model the overall system. 
 
Ultimately these types of questions target a fundamental gap in our understanding of the Golgi 
Arf-GEFs.  We know that they activate Arf1, and we know what activated Arf1 does.  But how 
and why are Gea1, Gea2, and Sec7 localized to different Golgi compartments?  How is the 
timing of their activation of Arf1 controlled?  Answering these questions will help us form a 
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complete model of the trafficking events that must happen at the early, medial, and late Golgi, 
and how Gea1, Gea2, and Sec7 are regulated to coordinate their roles. 
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- Appendices - 
 
              
 
Appendix I. Materials and Methods 
Antibodies and immunoprecipitations 
The anti-Gea2 rabbit polyclonal antibody was generated using purified Gea2 GEF domain 
(Covance) and used at a 1:500 dilution.  This antibody cross-reacts to some extent with purified 
recombinant Gea1 but fails to detect Gea1 in yeast extracts.  The anti-G6PDH rabbit polyclonal 
antibody was purchased from Sigma and used at a 1:30,000 dilution.  The anti-His6 mouse 
monoclonal antibody used to verify cleavage of His tags was purchased from Covance and used 
at a 1:500 dilution.   
 
The GFP nanobody resin used for immunoprecipitation experiments was made using purified 
GFP nanobody and NHS-activated Sepharose Fast Flow (GE Healthcare) (Kirchhofer et al., 
2009).  25 ODs of cells were suspended in lysis buffer (50 mM Tris-HCl pH 7.5, 0.2% NP40 
substitute, 150 mM NaCl, 1 mM EDTA, 1X complete protease inhibitor cocktail [Roche] and 1 
mM PMSF) before lysis by mechanical disruption.  After incubation, resin was washed three 
times with lysis buffer and proteins were eluted in SDS sample buffer.  
 
Yeast growth assays 
Yeast shuffling assays were used to assess in vivo sufficiency of Gea1 and Gea2 mutants 
(Gea2ΔC is residues 1-766). Double deletion strains (gea1Δgea2Δ and gea1Δgea2Δarf1Δ) were 
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maintained by a copy of GEA2 on a URA3, ARS-CEN plasmid.  LEU2, ARS-CEN plasmids 
carrying the mutant constructs were introduced, and cells were cultured overnight in -Leu 
media.  Cells were plated at 3-fold dilutions onto synthetic complete media or media with 5-
FOA and incubated at 30°C for two days before imaging. 
 
To test for sensitivity to the drug Congo Red, shuffled cells were plated at 3-fold dilutions onto 
synthetic complete media containing either 50 ng/µl or 100 ng/µl Congo Red (Sigma) and 
incubated at 30°C for two days before imaging. 
 
Protein purification 
Gea constructs were expressed with an N-terminal His6 tag in Rosetta2 E. coli cells, with 
expression induced overnight with 250 µM IPTG at 15°C.  Pelleted cultures were resuspended 
in 25 ml/L of culture of lysis buffer (40 mM Tris pH 8.0, 300 mM NaCl, 10% glycerol, 10 mM 
imidazole, 0.25X Roche complete protease inhibitor, 1 mM PMSF, 10 mM β-ME) before lysis by 
sonication.  After the lysate was clarified by centrifugation, protein constructs were purified via 
nickel affinity (Ni-NTA resin, Qiagen) in batch, followed by anion exchange (MonoQ, GE 
Healthcare), overnight cleavage of the His6 tag by TEV protease at 4°C, and gel filtration 
(Superdex 200, GE Healthcare), with a final buffer containing 20 mM Tris pH 8, 150 mM NaCl, 
and 1 mM DTT.  The Gea2GEF construct was expressed and purified similarly through the 
nickel affinity step, then incubated at room temperature overnight with TEV, before an 
additional round nickel binding and elution to remove any uncleaved protein. 
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Purification of Arf and Rab GTPases has previously been described in detail (Ha et al., 2005; 
Mcdonold and Fromme, 2014; Richardson and Fromme, 2015; Thomas and Fromme, 2016). 
Liposome preparation 
Lipid composition of PC, PC-Ni2+, TGN, and TGN-Ni2+ liposomes is described in Appendix II.  
Liposomes were prepared in HK buffer (20 mM HEPES pH 7.5, 150 mM KOAc) as described 
previously (Paczkowski and Fromme, 2016), with 100 nm filters used to extrude liposomes used 
for GEF activity assays and 400 nm filters used to extrude liposomes used for membrane 
pelleting assays. 
GEF activity assays 
GEF activity was measured as described previously (Richardson and Fromme, 2015).  All assays 
were carried out in HKM buffer (HK plus 2 mM MgCl2) at 30°C.  Arf1 exchange was measured 
after sequentially adding 200 µM GTP and 100 nM GEF to HKM with 333 µM liposomes (or 166 
µM liposomes, for Figure 6, E and F).  After equilibration for 5 minutes, Arf1 was added and 
native tryptophan fluorescence was measured for 12 minutes.  For assays testing the effect of 
preloaded GTPases, 500 nM Arf1, Arl1, Ypt1-His7, or Ypt6-His7 or 400 nM prenylated Ypt1 was 
added to HKM with liposomes, followed by 200 µM GTP and 2 mM EDTA.  After incubation 
for 12 minutes, 4 mM MgCl2 was added, followed by 100 nM GEF.  After 5 minutes of 
equilibration, 500 nM Arf1 was added and monitored for an additional 12 minutes.  Each assay 
was carried out in triplicate for statistical analysis. 
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Liposome pelleting assays 
Liposome pelleting assays were carried out as previously described (Paczkowski and Fromme, 
2016).  500 µM liposomes were mixed with HKM buffer.  To test intrinsic membrane binding of 
GEF constructs, 4 µg of each construct was incubated with liposomes for 10 minutes at room 
temperature before ultracentrifugation, separation of supernatant from pellet, and PAGE 
analysis.  For recruiting assays, 2 µg of each GTPase was activated by 15 minutes of EDTA-
mediated GTP exchange at 30°C before the addition of extra MgCl2 and finally 4 µg of GEF.  
Parallel reactions lacking liposomes were run with all sets of binding reactions to account for 
background pelleting of GEF constructs. 
 
PAGE gels were stained with Bio-Safe Coomassie (Bio-Rad) and imaged using a LI-COR 
Odyssey system.  Band intensities were quantified in ImageJ.  Percent GEF in pellet was 
calculated after subtraction of background pelleting for each construct.  Each set of reactions 
was performed in at least triplicate for statistical analysis. 
 
Microscopy 
Cells were cultured in either synthetic complete media or synthetic dropout media at 30°C and 
imaged in log phase. Note that Gea2ΔC in Figure 2.6 corresponds to residues 1-766. 
 
Images for Figures 2.1, 2.6, 4.3, 4.4 B, and 5.5 were captured using a CSU-X spinning disc 
confocal microscope system (Intelligent Imaging Innovations, Inc.) using a DMI600B 
microscope (Leica Biosystems), 100×/1.46 NA objective, and a QuantEM EMC CD camera 
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(Photometrics).  Images were acquired, leveled, and analyzed using Slidebook 5.0 software 
(Intelligent Imaging Innovations, Inc.).  Single confocal sections are shown.  After background 
subtraction to limit analysis to Golgi puncta and selection of individual cells, Pearson’s analysis 
was performed in Slidebook 5.0 to quantify colocalization of fluorescently tagged proteins. 
 
Images for Figure 4.4 C were captured using an Andor Revolution spinning disk confocal 
microscope with dual cameras for simultaneous red/green channel acquisition.  Images were 
leveled and analyzed using ImageJ.  Single confocal planes are shown. 
 
Images described in the Tables 4.2 and 5.1 and in the text were captured using a DeltaVision RT 
wide-field microscope (Applied Precision) followed by deconvolution in softWoRx.  Images 
were leveled and analyzed using ImageJ. 
 
Conservation analysis and mutant design 
Conservation analysis was carried out using ClustalW and visualized using WebLogo, 
secondary structure was predicted using PSIPRED, and surface analysis on the Gea2 molecular 
replacement model was visualized in PyMOL. 
 
SILAC mass spectrometry 
For mass spectrometry experiments, cells were grown in (-)Arg (-)Lys drop-out medium (‘light’ 
version complemented with standard arginine and lysine; ‘heavy’ version complemented with 
lysine 13C6, 15N2 and arginine 13C6, 15N4).  In this case, light and heavy media were used with 
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cells containing either wild type Gea2 or Gea2-HA.  Cells were harvested by centrifugation and 
incubated for 10 minutes with 0.375% formaldehyde before neutralization with glycine.  After 
mechanical disruption, lysates were incubated with anti-HA resin (Sigma).  Resin was washed 
with lysis buffer before bound proteins were eluted and eluates from light and heavy medium 
were mixed together, reduced, alkylated and precipitated.  After resuspension and digestion 
with trypsin, samples were dried in a SpeedVac evaporator, reconstituted and analysed by LC-
MS/MS using a 125 μM ID capillary C18 column and an Orbitrap XL mass spectrometer coupled 
with an Eksigent nanoflow system.  Database searching was performed using the SORCERER 
system (Sage-N Research) running the program SEQUEST.  After searching a target-decoy 
budding yeast database, results were filtered either based on probability score to achieve a 1% 
false positive rate or manual inspection.  Quantification of heavy/light peptide isotope ratios 
was performed using the Xpress program. 
 
Multi-angle light scattering (MALS) 
Proteins purified to homogeneity were exchanged into fresh buffer by serial concentration and 
redilution to a final concentration of 5 mg/ml, and separated in a Wyatt WTC-050S5 gel 
filtration column coupled to DAWN HELEOS-II light scattering and Optilab T-rEX refractive 
index detectors (Wyatt Technology) at room temperature.  Data were analyzed via ASTRA 6 
software to obtain the molecular weight of the sample. 
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Statistical tests 
Significance for Figure 1, Figure 2, Figure 6, E and F, and Figure 7 was determined using an 
unpaired t test with a Welch’s correction.  Significance for all other figures was determined by a 
one-way ANOVA with a Tukey post-test.  Error bars represent 95% confidence intervals. 
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PC PC-Ni2+ TGN TGN-Ni2+
Lipid
DOPC 99 94 24 24
POPC 6 6
DOPE 7 7
POPE 3 3
DOPS 1 1
POPS 2 2
DOPA 1 1
POPA 2 2
PI 29 24
PI(4)P 1 1
CDP-DAG 2 2
PO-DAG 4 4
DO-DAG 2 2
Ceramide (C18) 5 5
Nickel-DOGS 5 5
Cholesterol 10 10
DiR 1 1 1 1
Appendix II.  Composition of liposomes used in this study
Amount (Molar %)
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Name Description Vector Source
pCF1248 GEA2  driven by PGEA2  (URA3  maintenance plasmid for 
shuffling strains)
pRS416 This study
pCF1301 GEA1-GFP  driven by PGEA2 pRS415 This study
pCF1302 GEA2-GFP  driven by PGEA1 pRS415 This study
pCF1312 gea1ΔC  (1-761)-GFP  driven by PGEA1 pRS415 This study
pCF1313 gea2ΔC  (1-766)-GFP  driven by PGEA2 pRS415 This study
pCM09 gea1ΔHDS3  (1-1225)-GFP  driven by PGEA1 pRS415 This study
pCM10 GEA1  FL  (1-1408)-GFP  driven by PGEA1 pRS415 This study
pMG001 GEA2 FL  (1-1459)-GFP  driven by PGEA2 pRS415 This study
pMG002 gea2ΔHDS3  (1-1196)-GFP  driven by PGEA2 pRS415 This study
pMG033 gea1  (1-1408) Y991C-GFP pRS415 This study
YIplac211-iGFP-VRG4 Integrating plasmid for GFP-VRG4  by two-step gene YIplac211 Gift from B. Glick
Appendix III. Yeast expression plasmids used in this study and developed for future use
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Name Description Vector Source
pARF1 ARF1 pET3 Weiss 1989
pBCR314 SEC7  (203-2009) with a cleavable His6 tag pFastBacHT Richardson 2012
pCF1053 arf1ΔN17 pET28 Richardson 2012
pCF1163 GEA1 FL  (1-1408) with a cleavable His6 tag pET28 Richardson 2012
pCF1184 ARL1 pET23 McDonold 2014
pCF1299 GEA2ΔC  (1-782) with a cleavable His6 tag pET28 Richardson 2016
pCM14 YPT6  with C-terminal His7 tag and cleavable N-terminal 
GST  tag
pGEX-6P McDonold 2014
pLT35 MRS6  with cleavable N-terminal His6 tag pET28 Thomas 2016
pLT40 GDI1  with cleavable N-terminal GST tag pGEX-6P Thomas 2016
pLT41 BET2  with cleavable N-terminal His6 tag and Bet4 pCDF-Duet-1 Thomas 2016
pLT50 Full-length YPT1  with cleavable N-terminal GST tag pGEX-6P Thomas 2016
pMG005 GEA2 FL  (1-1459) with a cleavable His6 tag pET28 Richardson 2016
pMG006 C. glabrata  GEA  with a cleavable His6 tag pET28 This study
pMG007 K. lactis  GEA  with a cleavable His6 tag pET28 This study
pMG008 K. thermotolerans  GEA  with a cleavable His6 tag pET28 This study
pMG009 Z. rouxii  GEA  with a cleavable His6 tag pET28 This study
pMG010 GEA2  (1-1459) with a cleavable His6 tag pFastBacHT This study
pMG012 GEA1  (1-1408) with a cleavable His6 tag pFastBacHT This study
pMG013 C. thermophilum GEA  with a cleavable His6 tag pFastBacHT This study
pMG014 M. thermophila  GEA  with a cleavable His6 tag pFastBacHT This study
pMG015 S. stipitis  GEA  with a cleavable His6 tag pFastBacHT This study
pMG016 C. thermophilum  GEA  with a cleavable His6 tag pET28 This study
pMG017 gea1ΔHDS3  (1-1225) with a cleavable His6 tag pET28 This study
pMG020 gea2ΔHDS3  (1-1196) with a cleavable His6 tag pET28 Richardson 2016
pMG023 M. thermophila  GEA  with a cleavable His6 tag pET28 This study
pMG024 gea1ΔN14  (15-1408) with a cleavable His6 tag pET28 This study
pMG025 gea1  (1-1408) K127A with a cleavable His6 tag pET28 This study
pMG026 gea1  (1-1408) D166A with a cleavable His6 tag pET28 This study
pMG027 gea1  (1-1408) D467A with a cleavable His6 tag pET28 This study
pMG028 gea2  (1-1459) K124A with a cleavable His6 tag pET28 This study
pMG029 gea2  (1-1459) D163A with a cleavable His6 tag pET28 This study
pMG030 gea2  (1-1459) D485A with a cleavable His6 tag pET28 This study
pMG031 gea1  (1-1408) Y991C with a cleavable His6 tag pET28 This study
pMG032 gea2  (1-1459) Y1001C with a cleavable His6 tag pET28 This study
pMG034 gea2  (1-1459) with a cleavable His6 tag on a long linker pET28 This study
pMG035 gea2ΔC  (1-782) with a cleavable His6 tag on a long linker pET28 This study
Appendix IV. Bacterial expression plasmids used in this study and developed for future use
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Name Description Vector Source
pMG036 gea2GEF  (558-782) with a cleavable His6 tag pET28 This study
pNMT1 NMT1 pCYC Duronio 1990
pYC001 gea2  (1-1459) E18A, C19A pET28 This study
pYC002 gea2  (1-1459) R27A, K28A, K31A pET28 This study
pYC003 gea2  (1-1459) K124A pET28 This study
pYC004 gea2  (1-1459) T150A, H151A, C152A pET28 This study
pYC005 gea2  (1-1459) R153A, F154A, E155A pET28 This study
pYC006 gea2  (1-1459) D162A, D163A pET28 This study
pYC007 gea2  (1-1459) N187A, S188A pET28 This study
pYC008 gea2  (1-1459) Y191A, D192A pET28 This study
pYC009 gea2  (1-1459) C202A, N203A pET28 This study
pYC010 gea2  (1-1459) R205A, R206A, S207A, E208A pET28 This study
pYC011 gea2  (1-1459) R211A, N212A, Q215A pET28 This study
Ypt1-His7 YPT1  with C-terminal His7 tag and cleavable N-terminal 
GST  tag
pGEX-6P Gift from T. Bretscher
Appendix IV. (continued)
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Name Description Source
SEY6210 MATα suc2-∆9 ura3-52 his3-∆200 leu2-3,112 lys2-801 trp1-∆901 Robinson et al., 1988
SEY6210.1 MATa suc2-∆9 ura3-52 his3-∆200 leu2-3,112 lys2-801 trp1-∆901 Robinson et al., 1988
BY4741α MATα ura3-Δ0 his3-Δ1 leu2-Δ0 lys2-Δ0 Brachmann et al., 1998
CFY2376 SEY6210 SEC7-Mars::TRP1 GEA1-mNeonGreen::HIS3 This study
CFY2378 SEY6210 SEC7-Mars::TRP1 GEA2-mNeonGreen::HIS3 This study
CFY2490 SEY6210.1 GEA1-3xMars::TRP1 GFP-VRG4 This study
CFY2503 SEY6210.1 GEA2-3xMars::TRP1 GFP-VRG4 This study
CFY2872 BY4741α GEA1Δ::KANMX GEA2Δ::HIS3 +pCF1248 This study
CFY2873 BY4741α GEA1Δ::NatMX GEA2Δ::HIS3 arf1Δ::KANMX +pCF1248 This study
CFY1391 SEY6210.1 GEA1-GFP::HIS3 KEX2-Mars::TRP1 This study
CFY1348 SEY6210.1 GEA2-GFP::HIS3 KEX2-Mars::TRP1 This study
CFY1450 SEY6210.1 GEA1-MARS::TRP1 SVP26-GFP::HIS3 This study
CFY1536 SEY6210.1 GEA2-MARS::TRP1 SEC7-iRFP::KANMX SVP26-GFP::HIS3 This study
CFY2401 SEY6210.1 GEA2-3xMars::TRP1 This study
CFY2447 SEY6210.1 GEA1-3xMars::TRP1 leu2::GFP-GOS1::LEU2 This study
CFY2463 SEY6210.1 GEA2-3xMars::TRP1 leu2::GFP-GOS1::LEU2 This study
CFY2668 SEY6210.1 GEA1-3xMars::TRP1 leu2::GFP-BOS1::LEU2 This study
CFY2670 SEY6210.1 GEA2-3xMars::TRP1 leu2::GFP-BOS1::LEU2 This study
CFY2458 SEY6210.1 GEA2-HA::HIS3 leu2::GFP-GOS1::LEU2 This study
Appendix V.  Yeast strains used in this study
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